Referências
Artigos de referência
1. Poon LC, Yang H, Kapur A, et al. Global interim guidance on coronavirus disease 2019 (COVID-19) during pregnancy and puerperium from FIGO and allied partners: information for healthcare professionals. Int J Gynaecol Obstet. 2020 Jun;149(3):273-86.Texto completo Resumo
2. Allotey J, Stallings E, Bonet M, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2021 Mar 12:70(10);355-61.Texto completo Resumo
3. Delahoy MJ, Whitaker M, O’Halloran A, et al. Characteristics and maternal and birth outcomes of hospitalized pregnant women with laboratory-confirmed COVID-19 — COVID-NET, 13 states, March 1–August 22, 2020. MMWR Morb Mortal Wkly Rep. 2020 Sep 25;69(38):1347-54.Texto completo Resumo
4. International Federation of Gynecology and Obstetrics. Safe motherhood and COVID-19 – March 2021 update. 2021 [internet publication].Texto completo
5. Epelboin S, Labrosse J, De Mouzon J, et al. Obstetrical outcomes and maternal morbidities associated with COVID-19 in pregnant women in France: a national retrospective cohort study. PLoS Med. 2021 Nov 30;18(11):e1003857.Texto completo Resumo
6. Knight M, Bunch K, Cairns A, et al on behalf of MBRRACE-UK. Saving lives, improving mothers’ care rapid report: learning from SARS-CoV-2-related and associated maternal deaths in the UK March – May 2020. National perinatal epidemiology unit, University of Oxford. Aug 2020 [internet publication].Texto completo
7. Healthcare Quality Improvement Partnership. Maternal, newborn and infant clinical outcome review programme rapid report, 2021: learning from SARS-CoV-2 related and associated maternal deaths in the UK. Jul 2021 [internet publication].Texto completo
8. Royal College of Midwives and Royal College of Obstetricians and Gynaecologists. Coronavirus (COVID-19) infection and pregnancy. Mar 2022 [internet publication].Texto completo
9. Knight M, Bunch K, Vousden N, et al. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study. BMJ. 2020 Jun 8;369:m2107.Texto completo Resumo
10. Ellington S, Strid P, Tong VT, et al. Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status - United States, January 22-June 7, 2020. MMWR Morb Mortal Wkly Rep 2020 Jun 26;69(25):769-75.Texto completo
11. Ahlberg M, Neovius M, Saltvedt S, et al. Association of SARS-CoV-2 test status and pregnancy outcomes. JAMA. 2020 Sep 23;324(17):1782-5.Texto completo Resumo
12. Woodworth KR, Olsen EO, Neelam V, et al. Birth and infant outcomes following laboratory-confirmed SARS-CoV-2 infection in pregnancy - SET-NET, 16 jurisdictions, March 29-October 14, 2020. MMWR Morb Mortal Wkly Rep. 2020 Nov 6;69(44):1635-40.Texto completo Resumo
13. Jering KS, Claggett BL, Cunningham JW, et al. Clinical characteristics and outcomes of hospitalized women giving birth with and without COVID-19. JAMA Intern Med. 2021 May 1;181(5):714-7.Texto completo Resumo
14. Gurol-Urganci I, Jardine JE, Carroll F, et al. Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection at the time of birth in England: national cohort study. Am J Obstet Gynecol. 2021 Nov;225(5):522.e1-522.e11.Texto completo Resumo
15. Piekos SN, Roper RT, Hwang YM, et al. The effect of maternal SARS-CoV-2 infection timing on birth outcomes: a retrospective multicentre cohort study. Lancet Digit Health. 2022 Jan 13;4(2):e95-104.Texto completo Resumo
16. Marchand G, Patil AS, Masoud AT, et al. Systematic review and meta-analysis of COVID maternal and neonatal clinical features and pregnancy outcomes to June 3rd 2021. AJOG Glob Rep. 2022 Feb;2(1):100049.Texto completo Resumo
17. Metz TD, Clifton RG, Hughes BL, et al. Association of SARS-CoV-2 infection with serious maternal morbidity and mortality from obstetric complications. JAMA. 2022 Feb 22;327(8):748-59.Texto completo Resumo
18. Ferrara A, Hedderson M, Zhu Y, et al. Perinatal complications in individuals in California with or without SARS-CoV-2 infection during pregnancy. JAMA Intern Med. 2022 May 1;182(5):503-12.Texto completo Resumo
19. McClymont E, Albert AY, Alton GD, et al. Association of SARS-CoV-2 infection during pregnancy with maternal and perinatal outcomes. JAMA. 2 May 2022 [Epub ahead of print].Texto completo Resumo
20. Panagiotakopoulos L, Myers TR, Gee J, et al. SARS-CoV-2 infection among hospitalized pregnant women: reasons for admission and pregnancy characteristics — eight U.S. health care centers, March 1–May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020 Sep 23;69(38):1355-9.Texto completo Resumo
21. Khoury R, Bernstein PS, Debolt C, et al. Characteristics and outcomes of 241 births to women with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection at five New York City medical centers. Obstet Gynecol. 2020 Aug;136(2):273-82.Texto completo Resumo
22. Metz TD, Clifton RG, Hughes BL, et al. Disease severity and perinatal outcomes of pregnant patients with coronavirus disease 2019 (COVID-19). Obstet Gynecol. 2021 Apr 1;137(4):571-80.Texto completo Resumo
23. Flaherman VJ, Afshar Y, Boscardin J, et al. Infant outcomes following maternal infection with SARS-CoV-2: first report from the PRIORITY study. Clin Infect Dis. 2021 Nov 2;73(9):e2810-13.Texto completo Resumo
24. Vousden N, Ramakrishnan R, Bunch K, et al. Severity of maternal infection and perinatal outcomes during periods of SARS-CoV-2 wildtype, alpha, and delta variant dominance in the UK: prospective cohort study. BMJ Medicine. 2022 Mar 9;1:e000053.Texto completo
25. Norman M, Navér L, Söderling J, et al. Association of maternal SARS-CoV-2 infection in pregnancy with neonatal outcomes. JAMA. 2021 May 25;325(20):2076-86.Texto completo Resumo
26. DeSisto CL, Wallace BL, Simeone RM, et al. Risk for stillbirth among women with and without COVID-19 at delivery hospitalization - United States, March 2020-September 2021. MMWR Morb Mortal Wkly Rep. 2021 Nov 26;70(47):1640-45.Texto completo Resumo
27. Allotey J, Chatterjee S, Kew T, et al. SARS-CoV-2 positivity in offspring and timing of mother-to-child transmission: living systematic review and meta-analysis. BMJ. 2022 Mar 16;376:e067696.Texto completo Resumo
28. International Federation of Gynecology and Obstetrics. COVID-19 vaccination for pregnant and breastfeeding women. Mar 2021 [internet publication].Texto completo
29. American College of Obstetricians and Gynecologists (ACOG). COVID-19 vaccination considerations for obstetric–gynecologic care. Apr 2022 [internet publication].Texto completo
30. Centers for Disease Control and Prevention. Information about COVID-19 vaccines for people who are pregnant or breastfeeding. Mar 2022 [internet publication].Texto completo
31. UK Health Security Agency. COVID-19: the green book, chapter 14a: Coronavirus (COVID-19) vaccination information for public health professionals. Feb 2022 [internet publication].Texto completo
32. Adhikari EH, MacDonald L, SoRelle JA, et al. COVID-19 cases and disease severity in pregnancy and neonatal positivity associated with Delta (B.1.617.2) and Omicron (B.1.1.529) variant predominance. JAMA. 2022 Apr 19;327(15):1500-2.Texto completo Resumo
33. Fell DB, Dhinsa T, Alton GD, et al. Association of COVID-19 vaccination in pregnancy with adverse peripartum outcomes. JAMA. 2022 Apr 19;327(15):1478-87.Texto completo Resumo
34. Magnus MC, Örtqvist AK, Dahlqwist E, et al. Association of SARS-CoV-2 vaccination during pregnancy with pregnancy outcomes. JAMA. 2022 Apr 19;327(15):1469-77.Texto completo Resumo
35. Shimabukuro TT, Kim SY, Myers TR, et al. Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons. N Engl J Med. 2021 Jun 17;384(24):2273-82.Texto completo Resumo
36. Zauche L, Wallace B, Smoots AN, et al. Receipt of mRNA Covid-19 vaccines and risk of spontaneous abortion. N Engl J Med. 2021 Oct 14;385(16):1533-5.Texto completo Resumo
37. Kharbanda EO, Haapala J, DeSilva M, et al. Spontaneous abortion following COVID-19 vaccination during pregnancy. JAMA. 2021 Oct 26;326(16):1629-31.Texto completo Resumo
38. Magnus MC, Gjessing HK, Eide HN. et al. Covid-19 vaccination during pregnancy and first-trimester miscarriage. N Engl J Med. 2021 Nov 18;385(21):2008-10.Texto completo Resumo
39. UK Health Security Agency. COVID-19 vaccine weekly surveillance reports (weeks 39 to 50). Apr 2022 [internet publication].Texto completo
40. Lipkind HS, Vazquez-Benitez G, DeSilva M, et al. Receipt of COVID-19 vaccine during pregnancy and preterm or small-for-gestational-age at birth - eight integrated health care organizations, United States, December 15, 2020-July 22, 2021. MMWR Morb Mortal Wkly Rep. 2022 Jan 7;71(1):26-30.Texto completo Resumo
41. Hillson K, Costa Clemens S, Madhi SA, et al. Fertility rates and birth outcomes after ChAdOx1 nCoV-19 (AZD1222) vaccination. Lancet. 2021 Nov 6;398(10312):1683-4.Texto completo Resumo
42. Aharon D, Lederman M, Ghofranian A, et al. In vitro fertilization and early pregnancy outcomes after coronavirus disease 2019 (COVID-19) vaccination. Obstet Gynecol. 25 Jan 2022 [Epub ahead of print].Texto completo Resumo
43. Magee LA, von Dadelszen P, Kalafat E, et al. COVID-19 vaccination in pregnancy-number needed to vaccinate to avoid harm. Lancet Infect Dis. 2021 Dec;21(12):1627.Texto completo Resumo
44. Gill L, Jones C. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in neonatal cord blood after vaccination in pregnancy. Obstet Gynecol. 2021 May 1;137(5):894-6.Texto completo Resumo
45. Perl S, Uzan-Yulzari A, Klainer H, et al. SARS-CoV-2–specific antibodies in breast milk after COVID-19 vaccination of breastfeeding women. JAMA. 2021 May 18;325(19):2013-4.Texto completo Resumo
46. Gray KJ, Bordt EA, Atyeo C, et al. COVID-19 vaccine response in pregnant and lactating women: a cohort study. Am J Obstet Gynecol. 2021 Sep;225(3):303.Texto completo Resumo
47. Halasa NB, Olson SM, Staat MA, et al. Effectiveness of maternal vaccination with mRNA COVID-19 vaccine during pregnancy against COVID-19-associated hospitalization in infants aged <6 months - 17 states, July 2021-January 2022. MMWR Morb Mortal Wkly Rep. 2022 Feb 18;71(7):264-70.Texto completo Resumo
48. Berthelot N, Lemieux R, Garon-Bissonnette J, et al. Uptrend in distress and psychiatric symptomatology in pregnant women during the coronavirus disease 2019 pandemic. Acta Obstet Gynecol Scand. 2020 Jul;99(7):848-55.Texto completo Resumo
49. Papworth R, Harris A, Durcan G, et al. Maternal mental health during a pandemic. A rapid evidence review of Covid-19's impact. Mar 2021 [internet publication].Texto completo
50. Royal College of Midwives and Royal College of Obstetricians and Gynaecologists. Guidance for antenatal and postnatal services in the evolving coronavirus (COVID-19) pandemic. Oct 2020 [internet publication].Texto completo
51. Centers for Disease Control and Prevention. Coronavirus disease 2019 (COVID-19). Considerations for inpatient obstetric healthcare settings. Nov 2021 [internet publication].Texto completo
52. American College of Obstetricians and Gynecologists. COVID-19 FAQs for obstetrician-gynecologists, obstetrics. Mar 2022 [internet publication].Texto completo
53. World Health Organization. Clinical management of COVID-19: living guidance. Nov 2021 [internet publication].Texto completo
54. American Academy of Pediatrics. FAQs: management of infants born to mothers with suspected or confirmed COVID-19. Dec 2021 [internet publication].Texto completo
55. Salvatore CM, Han JY, Acker KP, et al. Neonatal management and outcomes during the COVID-19 pandemic: an observation cohort study. Lancet Child Adolesc Health. 2020 Oct;4(10):721-7.Texto completo Resumo
56. Dumitriu D, Emeruwa UN, Hanft E, et al. Outcomes of neonates born to mothers with severe acute respiratory syndrome coronavirus 2 infection at a large medical center in New York City. JAMA Pediatr. Oct 2020 [internet publication].Texto completo Resumo
57. Ronchi A, Pietrasanta C, Zavattoni M, et al. Evaluation of rooming-in practice for neonates born to mothers with severe acute respiratory syndrome coronavirus 2 infection in Italy. JAMA Pediatr. 2021 Mar 1;175(3):260-6.Texto completo Resumo
58. Flannery DD, Gouma S, Dhudasia MB, et al. Assessment of maternal and neonatal cord blood SARS-CoV-2 antibodies and placental transfer ratios. JAMA Pediatr. 2021 Jun 1;175(6):594-600.Texto completo Resumo
59. Royal College of Paediatrics and Child Health. BAPM - COVID-19: frequently asked questions within neonatal settings. Jan 2022 [internet publication].Texto completo
60. Resuscitation Council UK. COVID-19 resources: newborn life support. Sep 2021 [internet publication].Texto completo
61. Centers for Disease Control and Prevention. Care for breastfeeding women. Interim guidance on breastfeeding and breast milk feeds in the context of COVID-19. Dec 2021 [internet publication].Texto completo
62. Chambers C, Krogstad P, Bertrand K, et al. Evaluation for SARS-CoV-2 in breast milk from 18 infected women. JAMA. 2020 Oct 6;324(13):1347-8.Texto completo Resumo
63. Elliott J, Bodinier B, Whitaker M, et al. COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors. Eur J Epidemiol. 2021 Mar;36(3):299-309.Texto completo Resumo
64. American Academy of Dermatology. Clinical guidance for COVID-19. 2020 [internet publication].Texto completo
65. National Institute for Health and Care Excellence. COVID-19 rapid guideline: dermatological conditions treated with drugs affecting the immune response. Apr 2021 [internet publication].Texto completo
66. Gadarowski MB, Balogh EA, Bashyam AM, et al. Examining recommendations for the use of biologics and other systemic therapies during COVID-19: a review and comparison of available dermatology guidelines and patient registries. J Dermatolog Treat. Oct 2020 [internet publication].Texto completo Resumo
67. Vultaggio A, Agache I, Akdis CA, et al. Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statement. Allergy. 2020 Nov;75(11):2764-74. Resumo
68. International Psoriasis Council. IPC statement on the coronavirus (COVID-19) outbreak. Sep 2020 [internet publication].Texto completo
69. European Association of Dermatology and Venereology (EADV). Management of psoriasis patients under systemic treatments. Apr 2020 [internet publication].Texto completo
70. International Eczema Council. IEC statement on COVID-19. 2020 [internet publication].Texto completo
71. Specialist Pharmacy Service. Using COVID-19 vaccines in patients taking immunosuppressive medicines. Mar 2022 [internet publication].Texto completo
72. Gelfand JM, Armstrong AW, Bell S, et al. National psoriasis foundation COVID-19 task force guidance statements. Apr 2022 [internet publication].Texto completo
73. Kasperkiewicz M, Schmidt E, Fairley JA, et al. Expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic. J Eur Acad Dermatol Venereol. 2020 Jul;34(7):e302-3.Texto completo Resumo
74. Wollenberg A, Flohr C, Simon D, et al. European task force on atopic dermatitis statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection and atopic dermatitis. J Eur Acad Dermatol Venereol. 2020 Jun;34(6):e241-2.Texto completo Resumo
75. British Association of Dermatologists. Dermatology advice regarding medication acting on the immune system: adults, paediatrics and young people. Nov 2020 [internet publication].Texto completo
76. Medicines and Healthcare products Regulatory Agency. Temporary advice for management of oral retinoid medicines during the COVID-19 pandemic. Jun 2021 [internet publication].Texto completo
77. National Institute for Health and Care Excellence. COVID-19 rapid guideline: gastrointestinal and liver conditions treated with drugs affecting the immune response. Apr 2021 [internet publication].Texto completo
78. American Association for the Study of Liver Diseases. Clinical best practice advice for hepatology and liver transplant providers during the COVID-19 pandemic: AASLD expert panel consensus statement. Nov 2021 [internet publication].Texto completo
79. Boettler T, Marjot T, Newsome PN, et al. Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic. JHEP Rep. 2020 Oct;2(5):100169.Texto completo Resumo
80. NHS England. Triaging patients with lower gastrointestinal symptoms. Jun 2020 [internet publication].Texto completo
81. National Institute for Health and Care Excellence. Suspected cancer: recognition and referral. Dec 2021 [internet publication].Texto completo
82. Gralnek IM, Hassan C, Beilenhoff U, et al. ESGE and ESGENA position statement on gastrointestinal endoscopy and the COVID-19 pandemic. Endoscopy. 2020 Jun;52(6):483-90.Texto completo Resumo
83. Chiu PW, Ng SC, Inoue H, et al. Practice of endoscopy during COVID-19 pandemic: position statements of the Asian Pacific Society for Digestive Endoscopy (APSDE-COVID statements). Gut. 2020 Jun;69(6):991-6.Texto completo Resumo
84. Gralnek I, Hassan C, Beilenhoff U, et al. ESGE and ESGENA position statement on gastrointestinal endoscopy and COVID-19: an update on guidance during the post-lockdown phase and selected results from a membership survey. Endoscopy. 2020 Oct;52(10):891-8.Texto completo Resumo
85. Sultan S, Siddique SM, Altayar O, et al. AGA institute rapid review and recommendations on the role of pre-procedure SARS-CoV2 testing and endoscopy. Gastroenterology. 2020 Nov;159(5):1935-48.e5.Texto completo Resumo
86. Walsh CM, Fishman DS, Lerner DG, et al. Pediatric endoscopy in the era of coronavirus disease 2019: a North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition position paper. J Pediatr Gastroenterol Nutr. 2020 Jun;70(6):741-50.Texto completo Resumo
87. Wong GL, Wong VW, Thompson A, et al. Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement. Lancet Gastroenterol Hepatol. 2020 Aug;5(8):776-87.Texto completo Resumo
88. World Health Organization. Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19). Feb 2020 [internet publication].Texto completo
89. Ng WH, Tipih T, Makoah N, et al. Comorbidities in SARS-CoV-2 patients: a systematic review and meta-analysis. mBio. 2021 Feb 9;12(1):e03647-20.Texto completo Resumo
90. Pinato DJ, Zambelli A, Aguilar-Company J, et al. Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients. Cancer Discov. 2020 Oct 1;10(10):1465-74.Texto completo Resumo
91. Jee J, Foote MB, Lumish M, et al. Chemotherapy and COVID-19 outcomes in patients with cancer. J Clin Oncol. 2020 Aug 14:JCO2001307.Texto completo Resumo
92. Chavez-MacGregor M, Lei X, Zhao H, et al. Evaluation of COVID-19 mortality and adverse outcomes in US patients with or without cancer. JAMA Oncol. 2022 Jan 1;8(1):69-78.Texto completo Resumo
93. Lee LYW, Cazier JB, Starkey T, et al. COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study. Lancet Oncol. 2020 Oct;21(10):1309-16.Texto completo Resumo
94. Wang Q, Berger NA, Xu R. Analyses of risk, racial disparity, and outcomes among US patients with cancer and COVID-19 infection. JAMA Oncol. 2021 Feb 1;7(2):220-7.Texto completo Resumo
95. Fair Health. Risk factors for COVID-19 mortality among privately insured patients: a claims data analysis. Nov 2020 [internet publication].Texto completo
96. OnCovid Study Group; Pinato DJ, Patel M, et al. Time-dependent COVID-19 mortality in patients with cancer: an updated analysis of the OnCovid registry. JAMA Oncol. 2022 Jan 1;8(1):114-22.Texto completo Resumo
97. National Institute for Health and Care Excellence. COVID-19 rapid guideline: delivery of systemic anticancer treatments. Feb 2021 [internet publication].Texto completo
98. Weinkove R, McQuilten ZK, Adler J, et al. Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance. Med J Aust. 2020 Jun;212(10):481-9.Texto completo Resumo
99. National Institute for Health and Care Excellence. Interim treatment change options during the COVID-19 pandemic, endorsed by NHS England. Apr 2022 [internet publication].Texto completo
100. European Society for Medical Oncology. Cancer patient management during the COVID-19 pandemic. 2021 [internet publication].Texto completo
101. Curigliano G, Banerjee S, Cervantes A, et al. Managing cancer patients during the COVID-19 pandemic: an ESMO interdisciplinary expert consensus. Ann Oncol. 2020 Oct;31(10):1320-35.Texto completo Resumo
102. Marron JM, Joffe S, Jagsi R, et al. Ethics and resource scarcity: ASCO recommendations for the oncology community during the COVID-19 pandemic. J Clin Oncol. 2020 Jul 1;38(19):2201-5.Texto completo Resumo
103. COVID-19 Treatment Guidelines Panel. Coronavirus disease 2019 (COVID-19) treatment guidelines. National Institutes of Health. Apr 2022 [internet publication].Texto completo
104. American College of Cardiology. Delivery of cardio-oncology care during the COVID-19 pandemic. Jun 2020 [internet publication].Texto completo
105. Mukkada S, Bhakta N, Chantada GL, et al. Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study. Lancet Oncol. 2021 Aug 26;22(10):1416-26.Texto completo Resumo
106. Pinato DJ, Tabernero J, Bower M, et al. Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study. Lancet Oncol. 2021 Dec;22(12):1669-80.Texto completo Resumo
107. American Society of Clinical Oncology. COVID-19 vaccines & patients with cancer. Feb 2022 [internet publication].Texto completo
108. UK Chemotherapy Board. Clinicians FAQs and guidance on COVID-19 vaccine for patients receiving systemic anti-cancer therapy. Dec 2021 [internet publication].Texto completo
109. Goshen-Lago T, Waldhorn I, Holland R, et al. Serologic status and toxic effects of the SARS-CoV-2 BNT162b2 vaccine in patients undergoing treatment for cancer. JAMA Oncol. 2021 Oct 1;7(10):1507-13.Texto completo Resumo
110. Fendler A, Shepherd ST, Au L, et al. Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study. Nat Cancer. 2021 Dec;2(12):1305-20.Texto completo
111. Oosting SF, van der Veldt A, GeurtsvanKessel CH, et al. mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial. Lancet Oncol. 2021 Dec;22(12):1681-91.Texto completo Resumo
112. Wang W, Kaelber DC, Xu R, et al. Breakthrough SARS-CoV-2 infections, hospitalizations, and mortality in vaccinated patients with cancer in the US between December 2020 and November 2021. JAMA Oncol. 8 Apr 2022 [Epub ahead of print].Texto completo Resumo
113. Schmidt AL, Labaki C, Hsu CY, et al. COVID-19 vaccination and breakthrough infections in patients with cancer. Ann Oncol. 2022 Mar;33(3):340-6.Texto completo Resumo
114. National Institute for Health and Care Excellence. COVID-19 rapid guideline: delivery of radiotherapy. Feb 2021 [internet publication].Texto completo
115. Yahalom J, Dabaja BS, Ricardi U, et al. ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic. Blood. 2020 May 21;135(21):1829-32.Texto completo Resumo
116. Guckenberger M, Belka C, Bezjak A, et al. Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: an ESTRO-ASTRO consensus statement. Radiother Oncol. 2020 May;146:223-9.Texto completo Resumo
117. Liao Z, Rivin Del Campo E, Salem A, et al. Optimizing lung cancer radiation treatment worldwide in COVID-19 outbreak. Lung Cancer. 2020 Aug;146:230-5.Texto completo Resumo
118. Mehanna H, Hardman JC, Shenson JA, et al. Recommendations for head and neck surgical oncology practice in a setting of acute severe resource constraint during the COVID-19 pandemic: an international consensus. Lancet Oncol. 2020 Jul;21(7):e350-9.Texto completo Resumo
119. COVID-19 and people with neuromuscular disorders: World Muscle Society position and advice. Apr 2022 [internet publication].Texto completo
120. Jia N, Zhang G, Sun X, et al. Influence of angiotensin converting enzyme inhibitors/angiotensin receptor blockers on the risk of all-cause mortality and other clinical outcomes in patients with confirmed COVID-19: a systemic review and meta-analysis. J Clin Hypertens (Greenwich). 2021 Sep;23(9):1651-63.Texto completo Resumo
121. Asiimwe IG, Pushpakom S, Turner RM, et al. Cardiovascular drugs and COVID-19 clinical outcomes: a living systematic review and meta-analysis. Br J Clin Pharmacol. 2021 Dec;87(12):4534-45.Texto completo Resumo
122. Asiimwe I, Pushpakom S, Turner R, et al. Cardiovascular drugs and COVID-19 clinical outcomes: a systematic review and meta-analysis of randomized controlled trials. Br J Clin Pharmacol. 24 Mar 2022 [Epub ahead of print].Texto completo Resumo
123. Peñalvo J, Genbrugge E, Mertens E, et al. Insights into the association of ACEIs/ARBs use and COVID-19 prognosis: a multistate modelling study of nationwide hospital surveillance data from Belgium. BMJ Open. 2021 Sep 16;11(9):e053393.Texto completo Resumo
124. Khodneva Y, Malla G, Clarkson S, et al. What is the association of renin-angiotensin-aldosterone system inhibitors with COVID-19 outcomes: retrospective study of racially diverse patients? BMJ Open. 2022 Apr 12;12(4):e053961.Texto completo Resumo
125. British Cardiovascular Society and British Society for Heart Failure. BSH & BCS joint statement on ACEi or ARB in relation to COVID-19. Mar 2020 [internet publication].Texto completo
126. European Society of Cardiology Council on Hypertension. Position statement of the ESC Council on Hypertension on ACE-inhibitors and angiotensin receptor blockers. Mar 2020 [internet publication].Texto completo
127. American Heart Association, Heart Failure Society of America, American College of Cardiology. Patients taking ACE-i and ARBs who contract COVID-19 should continue treatment, unless otherwise advised by their physician. Mar 2020 [internet publication].Texto completo
128. Kario K, Morisawa M, Sukonthasarn A, et al. COVID-19 and hypertension-evidence and practical management: guidance from the HOPE Asia Network. J Clin Hypertens (Greenwich). 2020 Jul;22(7):1109-19.Texto completo Resumo
129. Lee SW, Ha EK, Yeniova AO, et al. Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching. Gut. 2021 Jan;70(1):76-84.Texto completo Resumo
130. Kim HB, Kim JH, Wolf BJ. Acid suppressant use in association with incidence and severe outcomes of COVID-19: a systematic review and meta-analysis. Eur J Clin Pharmacol. 2021 Nov 24;1-9.Texto completo Resumo
131. World Health Organization. Guiding principles for immunization activities during the COVID-19 pandemic: interim guidance, 26 March 2020. Mar 2020 [internet publication].Texto completo
132. Centers for Disease Control and Prevention. Schedule changes during the COVID-19 pandemic. Feb 2021 [internet publication].Texto completo
133. Public Health England. Statement from Joint Committee on Vaccination and Immunisation on immunisation prioritisation. Apr 2020 [internet publication].Texto completo
134. Causey K, Fullman N, Sorensen R, et al. Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study. Lancet. 2021 Aug 7;398(10299):522-34.Texto completo Resumo
135. Santoli JM, Lindley MC, DeSilva MB, et al. Effects of the COVID-19 pandemic on routine pediatric vaccine ordering and administration - United States, 2020. MMWR Morb Mortal Wkly Rep. 2020 May 15;69(19):591-3.Texto completo Resumo
136. Patel Murthy B, Zell E, Kirtland K, et al. Impact of the COVID-19 pandemic on administration of selected routine childhood and adolescent vaccinations - 10 U.S. jurisdictions, March-September 2020. MMWR Morb Mortal Wkly Rep. 2021 Jun 11;70(23):840-5.Texto completo Resumo
137. American Academy of Pediatrics. Guidance on providing pediatric well-care during COVID-19. Jan 2022 [internet publication].Texto completo
138. UK Health Security Agency. COVID-19: impact on childhood vaccinations: data to August 2021. Oct 2021 [internet publication].Texto completo
139. Centers for Disease Control and Prevention. Frequently asked influenza (flu) questions: 2021-2022 season. May 2022 [internet publication].Texto completo
140. UK Health Security Agency. National flu immunisation programme 2022 to 2023 letter. Apr 2022 [internet publication].Texto completo
141. Joint Committee of Vaccination and Immunisation: statement on the delivery of the HPV vaccine. Jul 2020 [internet publication].Texto completo
142. NHS England. Palivizumab passive immunisation against respiratory syncytial virus (RSV) in at-risk pre-term infants. Jul 2021 [internet publication].Texto completo
143. Anticoagulation Forum. Managing anticoagulation during the COVID-19 pandemic: frequently asked questions. Mar 2020 [internet publication].Texto completo
144. Medicines and Healthcare Products Regulatory Agency. Warfarin and other anticoagulants - monitoring of patients during the COVID-19 pandemic. Oct 2020 [internet publication].Texto completo
145. NHS National Patient Safety Alert. Inappropriate anticoagulation of patients with a mechanical heart valve. Jul 2021 [internet publication].Texto completo
146. National Institutes of Health. Coronavirus disease 2019 (COVID-19) treatment guidelines: antithrombotic therapy in patients with COVID-19. Feb 2022 [internet publication].Texto completo
147. National Institute for Health and Care Excellence. COVID-19 rapid guideline: managing COVID-19. May 2022 [internet publication].Texto completo
148. Speed V, Patel RK, Byrne R, et al. A perfect storm: root cause analysis of supra-therapeutic anticoagulation with vitamin K antagonists during the COVID-19 pandemic. Thromb Res. 2020 Aug;192:73-4.Texto completo Resumo
149. Handy A, Banerjee A, Wood A, et al. Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort. Heart. 10 Mar 2022 [Epub ahead of print].Texto completo Resumo
150. Center for the Study of Traumatic Stress. Taking care of patients during the coronavirus outbreak: a guide for psychiatrists. 2020 [internet publication].Texto completo
151. Substance Abuse and Mental Health Services Administration. Coronavirus (COVID-19). Mar 2022 [internet publication].Texto completo
152. Royal College of Psychiatrists. COVID-19: providing medication. 2020 [internet publication].Texto completo
153. Kahl KG, Correll CU. Management of patients with severe mental illness during the coronavirus disease 2019 pandemic. JAMA Psychiatry. 2020 Sep 1;77(9):977-8.Texto completo Resumo
154. Yalçın N, Ak S, Demirkan K. Do psychotropic drugs used during COVID-19 therapy have an effect on the treatment process? Eur J Hosp Pharm. 2021 Jan;28(1):e2.Texto completo Resumo
155. Mental Health Foundation. The COVID-19 pandemic, financial inequality and mental health. May 2020 [internet publication].Texto completo
156. Vai B, Mazza MG, Delli Colli C, et al. Mental disorders and risk of COVID-19-related mortality, hospitalisation, and intensive care unit admission: a systematic review and meta-analysis. Lancet Psychiatry. 2021 Sep;8(9):797-812.Texto completo Resumo
157. Fond G, Nemani K, Etchecopar-Etchart D, et al. Association between mental health disorders and mortality among patients with COVID-19 in 7 countries: a systematic review and meta-analysis. JAMA Psychiatry. 2021 Nov 1;78(11):1208-17.Texto completo Resumo
158. Ceban F, Nogo D, Carvalho IP, et al. Association between mood disorders and risk of COVID-19 infection, hospitalization, and death: a systematic review and meta-analysis. JAMA Psychiatry. 2021 Oct 1;78(10):1079-91.Texto completo Resumo
159. Tzur Bitan D, Kridin K, Dov Cohen A, et al. COVID-19 hospitalisation, mortality, vaccination, and postvaccination trends among people with schizophrenia in Israel: a longitudinal cohort study. Lancet Psychiatry. 2021 Oct;8(10):901-8.Texto completo Resumo
160. Murphy S, O'Reilly D, Owen R, et al. Variations in COVID-19 vaccination uptake among people in receipt of psychotropic drugs: cross-sectional analysis of a national population-based prospective cohort. Br J Psychiatry. 7 Mar 2022 [Epub ahead of print].Texto completo Resumo
161. Czeisler MÉ , Lane RI, Petrosky E, et al. Mental health, substance use, and suicidal ideation during the COVID-19 pandemic — United States, June 24–30, 2020. MMWR Morb Mortal Wkly Rep. 2020 Aug 14;69:1049–57.Texto completo
162. Bryant-Genevier, Rao CY, Lopes-Cardozo B, et al. Symptoms of depression, anxiety, post-traumatic stress disorder, and suicidal ideation among state, tribal, local, and territorial public health workers during the COVID-19 pandemic - United States, March-April 2021. MMWR Morb Mortal Wkly Rep. 2021 Dec 3;70(48):1680-5.Texto completo Resumo
163. Czeisler ME, Board A, Thierry JM, et al. Mental health and substance use among adults with disabilities during the COVID-19 pandemic - United States, February-March 2021. MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1142-9.Texto completo Resumo
164. Czeisler ME, Rohan EA, Melillo S, et al. Mental health among parents of children aged <18 years and unpaid caregivers of adults during the COVID-19 pandemic - United States, December 2020 and February-March 2021. MMWR Morb Mortal Wkly Rep. 2021 Jun 18;70(24):879-87.Texto completo Resumo
165. Ettman CK, Abdalla SM, Cohen GH, et al. Prevalence of depression symptoms in US adults before and during the COVID-19 pandemic. JAMA Netw Open. 2020 Sep 1;3(9):e2019686.Texto completo Resumo
166. Vahratian A, Blumberg SJ, Terlizzi EP, et al. Symptoms of anxiety or depressive disorder and use of mental health care among adults during the COVID-19 pandemic - United States, August 2020-February 2021. MMWR Morb Mortal Wkly Rep. 2021 Apr 2;70(13):490-4.Texto completo Resumo
167. Jia H, Guerin RJ, Barile JP, et al. National and state trends in anxiety and depression severity scores among adults during the COVID-19 pandemic - United States, 2020-2021. MMWR Morb Mortal Wkly Rep. 2021 Oct 8;70(40):1427-32.Texto completo Resumo
168. Pan KY, Kok AA, Eikelenboom M, et al. The mental health impact of the COVID-19 pandemic on people with and without depressive, anxiety, or obsessive-compulsive disorders: a longitudinal study of three Dutch case-control cohorts. Lancet Psychiatry. 2021 Feb;8(2):121-9.Texto completo Resumo
169. van der Velden PG, Contino C, Das M, et al. Differences in mental health problems, coping self-efficacy and social support between adults victimised before and adults victimised after the COVID-19 outbreak: population-based prospective study. Br J Psychiatry. 2022 Jan 24:1-7.Texto completo Resumo
170. Wong SYS, Zhang D, Sit RWS, et al. Impact of COVID-19 on loneliness, mental health, and health service utilisation: a prospective cohort study of older adults with multimorbidity in primary care. Br J Gen Pract. 2020 Oct 29;70(700):e817-24.Texto completo Resumo
171. Zaninotto P, Iob E, Demakakos P, et al. Immediate and longer-term changes in the mental health and well-being of older adults in England during the COVID-19 pandemic. JAMA Psychiatry. 2021 Dec 22;e213749.Texto completo Resumo
172. Di Gessa G, Price D. The impact of shielding during the COVID-19 pandemic on mental health: evidence from the English Longitudinal Study of Ageing. Br J Psychiatry. 4 Apr 2022 [Epub ahead of print].Texto completo Resumo
173. Wilke J, Hollander K, Mohr L, et al. Drastic reductions in mental well-being observed globally during the COVID-19 pandemic: results from the ASAP survey. Front Med (Lausanne). 2021 Mar 26;8:578959.Texto completo Resumo
174. COVID-19 Mental Disorders Collaborators. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet. 2021 Nov 6;398(10312):1700-12.Texto completo Resumo
175. Iob E, Steptoe A, Fancourt D. Abuse, self-harm and suicidal ideation in the UK during the COVID-19 pandemic. Br J Psychiatry. 2020 Oct;217(4):543-6.Texto completo Resumo
176. Office for Health Improvement and Disparities. COVID-19: mental health and wellbeing surveillance report. Important findings so far. Apr 2022 [internet publication].Texto completo
177. O'Connor RC, Wetherall K, Cleare S, et al. Mental health and wellbeing during the COVID-19 pandemic: longitudinal analyses of adults in the UK COVID-19 mental health & wellbeing study. Br J Psychiatry. 2020 Oct 21:1-17 [internet publication].Texto completo Resumo
178. Pierce M, McManus S, Hope H, et al. Mental health responses to the COVID-19 pandemic: a latent class trajectory analysis using longitudinal UK data. Lancet Psychiatry. 2021 Jul;8(7):610-9.Texto completo Resumo
179. Di Gessa G, Maddock J, Green MJ, et al. Pre-pandemic mental health and disruptions to healthcare, economic, and housing outcomes during COVID –19: evidence from 12 UK longitudinal studies. Br J Psychiatry. 2021:1-10.Texto completo
180. Das-Munshiabe J, Chang CK, Bakolisf I, et al. All-cause and cause-specific mortality in people with mental disorders and intellectual disabilities, before and during the COVID-19 pandemic: cohort study. Lancet Reg Health Eur. 2021 Dec;11:100228.Texto completo
181. Carr MJ, Steeg S, Webb RT, et al. Effects of the COVID-19 pandemic on primary care-recorded mental illness and self-harm episodes in the UK: a population-based cohort study. Lancet Public Health. 2021 Feb;6(2):e124-35.Texto completo Resumo
182. Wathelet M, Duhem S, Vaiva G, et al. Factors associated with mental health disorders among university students in France confined during the COVID-19 pandemic. JAMA Netw Open. 2020 Oct 1;3(10):e2025591.Texto completo Resumo
183. Raina P, Wolfson C, Griffith L, et al. A longitudinal analysis of the impact of the COVID-19 pandemic on the mental health of middle-aged and older adults from the Canadian longitudinal study on aging. Nature Aging. 2021;1:1137–47.Texto completo
184. Pirkis J, John A, Shin S, et al. Suicide trends in the early months of the COVID-19 pandemic: an interrupted time-series analysis of preliminary data from 21 countries. Lancet Psychiatry. 2021 Jul;8(7):579-88.Texto completo Resumo
185. Grocke-Dewey M, Hardison-Moody A, Haynes-Maslow L, et al. Examining the relationship between physical activity and mental health during the COVID-19 pandemic across five U.S. States. Prev Med Rep. 2021 Dec;24:101537.Texto completo Resumo
186. Oka T, Kubo T, Kobayashi N, et al. Multiple time measurements of multidimensional psychiatric states from immediately before the COVID-19 pandemic to one year later: a longitudinal online survey of the Japanese population. Transl Psychiatry. 2021 Nov 11;11(1):573.Texto completo Resumo
187. Xie Y, Xu E, Al-Aly Z. Risks of mental health outcomes in people with covid-19: cohort study. BMJ. 2022 Feb 16;376:e068993.Texto completo Resumo
188. The Childhood Trust. Children in lockdown: the consequences of the coronavirus crisis for children living in poverty. Jun 2020 [internet publication].Texto completo
189. American Academy of Pediatrics. Interim guidance on supporting the emotional and behavioral health needs of children, adolescents, and families during the COVID-19 pandemic. Dec 2021 [internet publication].Texto completo
190. Bignardi G, Dalmaijer ES, Anwyl-Irvine AL, et al. Longitudinal increases in childhood depression symptoms during the COVID-19 lockdown. Arch Dis Child. 2020 Dec 9;106(8):791-7.Texto completo Resumo
191. Loades ME, Chatburn E, Higson-Sweeney N, et al. Rapid systematic review: the impact of social isolation and loneliness on the mental health of children and adolescents in the context of COVID-19. J Am Acad Child Adolesc Psychiatry. 2020 Nov;59(11):1218-39.Texto completo Resumo
192. Rider EA, Ansari E, Varrin PH, et al. Mental health and wellbeing of children and adolescents during the covid-19 pandemic. BMJ. 2021 Aug 24;374:n1730.Texto completo Resumo
193. NHS Digital. Mental health of children and young people in England, 2020: wave 1 follow up to the 2017 survey. Oct 2020 [internet publication].Texto completo
194. Robinson J. Peaks in number of young people prescribed antidepressants coincide with lockdowns. PJ. 2021 Jun;306(7950):306.Texto completo
195. Thorisdottir IE, Asgeirsdottir B, Kristjansson AL, et al. Depressive symptoms, mental wellbeing, and substance use among adolescents before and during the COVID-19 pandemic in Iceland: a longitudinal, population-based study. Lancet Psychiatry. 2021 Aug;8(8):663-72.Texto completo Resumo
196. Leeb RT, Bitsko RH, Radhakrishnan L, et al. Mental health-related emergency department visits among children aged <18 years during the COVID-19 pandemic - United States, January 1-October 17, 2020. MMWR Morb Mortal Wkly Rep. 2020 Nov 13;69(45):1675-80.Texto completo Resumo
197. Radhakrishnan L, Leeb RT, Bitsko RH, et al. Pediatric emergency department visits associated with mental health conditions before and during the COVID-19 pandemic - United States, January 2019-January 2022. MMWR Morb Mortal Wkly Rep. 2022 Feb 25;71(8):319-24.Texto completo Resumo
198. Yard E, Radhakrishnan L, Ballesteros MF, et al. Emergency department visits for suspected suicide attempts among persons aged 12-25 years before and during the COVID-19 pandemic - United States, January 2019-May 2021. MMWR Morb Mortal Wkly Rep. 2021 Jun 18;70(24):888-94.Texto completo Resumo
199. Charpignon ML, Ontiveros J, Sundaresan S, et al. Evaluation of suicides among US adolescents during the COVID-19 pandemic. JAMA Pediatr. 25 Apr 2022 [Epub ahead of print].Texto completo Resumo
200. Jones SE, Ethier KA, Hertz M, et al. Mental health, suicidality, and connectedness among high school students during the COVID-19 pandemic - adolescent behaviors and experiences survey, United States, January-June 2021. MMWR Suppl. 2022 Apr 1;71(3):16-21.Texto completo Resumo
201. American Academy of Pediatrics. AAP-AACAP-CHA declaration of a national emergency in child and adolescent mental health. Oct 2021 [internet publication].Texto completo
202. Verlenden J, Pampati S, Rasberry C, et al. Association of children’s mode of school instruction with child and parent experiences and well-being during the COVID-19 pandemic — COVID Experiences Survey, United States, October 8-November 13, 2020. MMWR Morb Mortal Wkly Rep. 2021 Mar 19;70(11):369-76.Texto completo Resumo
203. Kisely S, Warren N, McMahon L, et al. Occurrence, prevention, and management of the psychological effects of emerging virus outbreaks on healthcare workers: rapid review and meta-analysis. BMJ. 2020 May 5;369:m1642.Texto completo Resumo
204. Schwartz R, Sinskey JL, Anand U, et al. Addressing postpandemic clinician mental health : a narrative review and conceptual framework. Ann Intern Med. 2020 Dec 15;173(12):981-8.Texto completo Resumo
205. Barello S, Palamenghi L, Graffigna G. Burnout and somatic symptoms among frontline healthcare professionals at the peak of the Italian COVID-19 pandemic. Psychiatry Res. 2020 Aug;290:113129.Texto completo Resumo
206. NHS England. NHS staff survey results. 2020 [internet publication].Texto completo
207. Centers for Disease Control and Prevention. Coronavirus disease 2019 (COVID-19): coping with stress. Mar 2022 [internet publication].Texto completo
208. Centers for Disease Control and Prevention. Emergency responders: tips for taking care of yourself. Mar 2018 [internet publication].Texto completo
209. World Health Organization. WHO briefing note: mental health and psychosocial considerations during the COVID-19 outbreak. Mar 2020 [internet publication].Texto completo
210. National Institute for Health and Care Excellence. COVID-19 rapid guideline: children and young people who are immunocompromised. Aug 2020 [internet publication].Texto completo
211. Rosenthal CM, Thompson LA. Child abuse awareness month during the coronavirus disease 2019 pandemic. JAMA Pediatr. 2020 Aug 1;174(8):812.Texto completo Resumo
212. Sidpra J, Abomeli D, Hameed B, et al. Rise in the incidence of abusive head trauma during the COVID-19 pandemic. Arch Dis Child. 2021 Mar;106(3):e14.Texto completo Resumo
213. American Academy of Pediatrics. Caring for children and youth with special health care needs during the COVID-19 pandemic. Feb 2022 [internet publication].Texto completo
214. Klein JD, Koletzko B, El-Shabrawi MH, et al. Promoting and supporting children's health and healthcare during COVID-19 - International Paediatric Association position statement. Arch Dis Child. 2020 Jul;105(7):620-4.Texto completo Resumo
215. Royal College of Paediatrics and Child Health. Safeguarding, looked after children and vulnerable children processes in England, Wales and Northern Ireland. Apr 2021 [internet publication].Texto completo
216. Medicines and Healthcare Products Regulatory Agency. Valproate pregnancy prevention programme: temporary advice for management during coronavirus (COVID-19). May 2020 [internet publication].Texto completo
217. Lakkireddy DR, Chung MK, Gopinathannair R, et al. Guidance for cardiac electrophysiology during the coronavirus (COVID-19) pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association. Circulation. 2020 May 26;141(21):e823-31.Texto completo Resumo
218. Zaman S, MacIsaac AI, Jennings GLR, et al. Cardiovascular disease and COVID-19: Australian/New Zealand consensus statement. Med J Aust. 2020 Apr 3;213(4):182-7.Texto completo Resumo
219. Kumar S, Haqqani H, Wynn G, et al. Position statement on the management of cardiac electrophysiology and cardiac Implantable electronic devices in Australia during the COVID-19 pandemic: a living document. Heart, Lung and Circulation. 2020 Jun 01;29(6):E57-68.Texto completo
220. Task Force for the management of COVID-19 of the European Society of Cardiology. ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up. Eur Heart J. 2022 Mar 14;43(11):1059-103.Texto completo Resumo
221. Association of Laparoscopic Surgeons of Great Britain and Northern Ireland. Laparoscopy in the COVID-19 environment - ALSGBI position statement. Apr 2020 [internet publication].Texto completo
222. Pavan N, Crestani A, Abrate A, et al. Risk of virus contamination through surgical smoke during minimally invasive surgery: a systematic review of the literature on a neglected issue revived in the COVID-19 pandemic era. Eur Urol Focus. 2020 Sep 15;6(5):1058-69.Texto completo Resumo
223. de Leeuw RA, Burger NB, Ceccaroni M, et al. COVID-19 and laparoscopic surgery: scoping review of current literature and local expertise. JMIR Public Health Surveill. 2020 Jun 23;6(2):e18928.Texto completo Resumo
224. Collings AT, Jeyarajah 2DR, Hanna NM, et al. SAGES 2022 guidelines regarding the use of laparoscopy in the era of COVID-19. Surg Endosc. 2022 May;36(5):2723-33.Texto completo Resumo
225. Siah KTH, Rahman MM, Ong AML, et al. The practice of gastrointestinal motility laboratory during COVID-19 pandemic: position statements of the Asian Neurogastroenterology and Motility Association (ANMA-GML-COVID-19 position statements). J Neurogastroenterol Motil. 2020 Jul 30;26(3):299-310.Texto completo Resumo
226. National Institute for Health and Care Excellence. COVID-19 rapid guideline: rearranging planned care in hospitals and diagnostic services. Jul 2020 [internet publication].Texto completo
227. El-Boghdadly K, Cook TM, Goodacre T, et al. Timing of elective surgery and risk assessment after SARS-CoV-2 infection: an update: a multidisciplinary consensus statement on behalf of the Association of Anaesthetists, Centre for Perioperative Care, Federation of Surgical Specialty Associations, Royal College of Anaesthetists, Royal College of Surgeons of England. Anaesthesia. 22 Feb 2022 [Epub ahead of print].Texto completo Resumo
228. Royal College of Surgeons of England. Recovery of surgical services during and after COVID-19. May 2020 [internet publication].Texto completo
229. American College of Surgeons. Clinical issues and guidance. Jul 2021 [internet publication].Texto completo
230. Mouton C, Hirschmann MT, Ollivier M, et al. COVID-19 - ESSKA guidelines and recommendations for resuming elective surgery. J Exp Orthop. 2020 May 13;7(1):28.Texto completo Resumo
231. Parvizi J, Gehrke T, Krueger CA, et al. Resuming elective orthopaedic surgery during the COVID-19 pandemic: guidelines developed by the International Consensus Group (ICM). J Bone Joint Surg Am. 2020 Jul 15;102(14):1205-12.Texto completo Resumo
232. Shah PB, Welt FGP, Mahmud E, et al. Triage considerations for patients referred for structural heart disease intervention during the COVID-19 pandemic: an ACC/SCAI position statement. JACC Cardiovasc Interv. 2020 Jun 22;13(12):1484-8.Texto completo Resumo
233. Hands K, Taylor C, Kotzé A, et al. Preoperative patient blood management during the SARS-CoV-2 pandemic. Br J Haematol. 2021 Jun;193(6):1087-92.Texto completo Resumo
234. American College of Surgeons. COVID-19 guidelines for triage of emergency general surgery patients. Dec 2020 [internet publication].Texto completo
235. NELA Project Team. The impact of COVID-19 on emergency laparotomy – an interim report of the national emergency laparotomy audit, 23 March 2020 – 30 September 2020. London: Royal College of Anaesthetists, 2021.Texto completo
236. COVIDSurg Collaborative. Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score. Br J Surg. 2021 Nov 11;108(11):1274-92.Texto completo Resumo
237. Royal College of Psychiatrists. COVID-19: eating disorder services. 2020 [internet publication].Texto completo
238. American Academy of Pediatrics. Obesity management and treatment during COVID-19. Sep 2021 [internet publication].Texto completo
239. Boelaert K, Visser WE, Taylor PN, et al. Endocrinology in the time of COVID-19: management of hyperthyroidism and hypothyroidism. Eur J Endocrinol. 2020 Jul;183(1):G33-9.Texto completo Resumo
240. Jeffery MM, D'Onofrio G, Paek H, et al. Trends in emergency department visits and hospital admissions in health care systems in 5 states in the first months of the COVID-19 pandemic in the US. JAMA Intern Med. 2020 Oct 1;180(10):1328-33.Texto completo Resumo
241. Baum A, Schwartz MD. Admissions to veterans affairs hospitals for emergency conditions during the COVID-19 pandemic. JAMA. 2020 Jun 5;324(1):96-9.Texto completo Resumo
242. Radhakrishnan L, Carey K, Hartnett KP, et al. Pediatric emergency department visits before and during the COVID-19 pandemic - United States, January 2019-January 2022. MMWR Morb Mortal Wkly Rep. 2022 Feb 25;71(8):313-8.Texto completo Resumo
243. Bodilsen J, Brønnum Nielsen P, Søgaard M, et al. Hospital admission and mortality rates for non-covid diseases in Denmark during covid-19 pandemic: nationwide population based cohort study. BMJ. 2021 May 24;373:n1135.Texto completo Resumo
244. Farrow L, Gardner W, Tang C, et al. Impact of COVID-19 on opioid use in those awaiting hip and knee arthroplasty: a retrospective cohort study. BMJ Qual Saf. 14 Sep 2021 [Epub ahead of print]. Resumo
245. Williams R, Jenkins DA, Ashcroft DM, et al. Diagnosis of physical and mental health conditions in primary care during the COVID-19 pandemic: a retrospective cohort study. Lancet Public Health. 2020 Oct;5(10):e543-50.Texto completo Resumo
246. Topriceanu CC, Wong A, Moon JC, et al. Evaluating access to health and care services during lockdown by the COVID-19 survey in five UK national longitudinal studies. BMJ Open. 2021 Mar 18;11(3):e045813.Texto completo Resumo
247. Royal College of Paediatrics and Child Health. Advice for parents during coronavirus. 2021 [internet publication].Texto completo
248. Mafham MM, Spata E, Goldacre R, et al. COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England. Lancet. 2020 Aug 8;396(10248):381-9.Texto completo Resumo
249. Kwok CS, Gale CP, Kinnaird T, et al. Impact of COVID-19 on percutaneous coronary intervention for ST-elevation myocardial infarction. Heart. 2020 Dec;106(23):1805-11.Texto completo Resumo
250. Wu J, Mamas MA, Mohamed MO, et al. Place and causes of acute cardiovascular mortality during the COVID-19 pandemic. Heart. 2021 Jan;107(2):113-9.Texto completo Resumo
251. Solomon MD, Nguyen-Huynh M, Leong TK, et al. Changes in patterns of hospital visits for acute myocardial infarction or ischemic stroke during COVID-19 surges. JAMA. 2021 Jul 6;326(1):82-4.Texto completo Resumo
252. Wadhera R, Figueroa JF, Rodriguez F, et al. Racial and ethnic disparities in heart and cerebrovascular disease deaths during the COVID-19 pandemic in the United States. Circulation. 2021 Jun 15;143(24):2346-54.Texto completo Resumo
253. Mesnier J, Cottin Y, Coste P, et al. Hospital admissions for acute myocardial infarction before and after lockdown according to regional prevalence of COVID-19 and patient profile in France: a registry study. Lancet Public Health. 2020 Oct;5(10):e536-42.Texto completo Resumo
254. Mohammad MA, Koul S, Olivecrona GK, et al. Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic. Heart. Oct 2020 [internet publication].Texto completo Resumo
255. Rattka M, Dreyhaupt J, Winsauer C, et al. Effect of the COVID-19 pandemic on mortality of patients with STEMI: a systematic review and meta-analysis. Heart. 2020 Dec 17 [Epub ahead of print].Texto completo Resumo
256. Holt A, Gislason GH, Schou M, et al. New-onset atrial fibrillation: incidence, characteristics, and related events following a national COVID-19 lockdown of 5.6 million people. Eur Heart J. 2020 Jun 1;41(32):3072-9.Texto completo Resumo
257. You Y, Niu Y, Sun F, et al. Impact of COVID-19 pandemic on haemorrhagic stroke admissions: a systematic review and meta-analysis. BMJ Open. 2021 Dec 14;11(12):e050559.Texto completo Resumo
258. Kamrath C, Mönkemöller K, Biester T, et al. Ketoacidosis in children and adolescents with newly diagnosed type 1 diabetes during the COVID-19 pandemic in Germany. JAMA. 2020 Aug 25;324(8):801-4.Texto completo Resumo
259. Rabbone I, Schiaffini R, Cherubini V, et al. Has COVID-19 delayed the diagnosis and worsened the presentation of type 1 diabetes in children? Diabetes Care. 2020 Nov;43(11):2870-2.Texto completo Resumo
260. Unsworth R, Wallace S, Oliver NS, et al. New-onset type 1 diabetes in children during COVID-19: multicenter regional findings in the U.K. Diabetes Care. 2020 Nov;43(11):e170-1.Texto completo Resumo
261. Carr MJ, Wright AK, Leelarathna L, et al. Impact of COVID-19 on diagnoses, monitoring, and mortality in people with type 2 diabetes in the UK. Lancet Diabetes Endocrinol. 2021 Jul;9(7):413-5.Texto completo Resumo
262. Misra S, Barron E, Vamos E, et al. Temporal trends in emergency admissions for diabetic ketoacidosis in people with diabetes in England before and during the COVID-19 pandemic: a population-based study. Lancet Diabetes Endocrinol. 2021 Oct;9(10):671-80.Texto completo Resumo
263. Patel SY, McCoy RG, Barnett ML, et al. Diabetes care and glycemic control during the COVID-19 pandemic in the United States. JAMA Intern Med. 2021 Oct 1;181(10):1412-4.Texto completo Resumo
264. Hatoun J, Correa ET, Donahue SMA, et al. Social distancing for COVID-19 and diagnoses of other infectious diseases in children. Pediatrics. 2020 Oct;146(4):e2020006460.Texto completo Resumo
265. Olsen SJ, Azziz-Baumgartner E, Budd AP, et al. Decreased influenza activity during the COVID-19 pandemic — United States, Australia, Chile, and South Africa, 2020. MMWR Morb Mortal Wkly Rep. 2020 Sep 18;69(37):1305-9.Texto completo Resumo
266. Kadambari S, Goldacre R, Morris E, et al. Indirect effects of the covid-19 pandemic on childhood infection in England: population based observational study. BMJ. 2022 Jan 12;376:e067519.Texto completo Resumo
267. Fakih MG, Bufalino A, Sturm L, et al. Coronavirus disease 2019 (COVID-19) pandemic, central-line-associated bloodstream infection (CLABSI), and catheter-associated urinary tract infection (CAUTI): the urgent need to refocus on hardwiring prevention efforts. Infect Control Hosp Epidemiol. 2022 Jan;43(1):26-31.Texto completo Resumo
268. Ray LC, Collins JP, Griffin PM, et al. Decreased incidence of infections caused by pathogens transmitted commonly through food during the COVID-19 pandemic - Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2017-2020. MMWR Morb Mortal Wkly Rep. 2021 Sep 24;70(38):1332-6.Texto completo Resumo
269. Hogan AB, Jewell BL, Sherrard-Smith E, et al. Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study. Lancet Glob Health. 2020 Sep;8(9):e1132-e1141.Texto completo Resumo
270. Kaufman HW, Chen Z, Niles J, et al. Changes in the number of US patients with newly identified cancer before and during the coronavirus disease 2019 (COVID-19) pandemic. JAMA Netw Open. 2020 Aug 3;3(8):e2017267.Texto completo Resumo
271. Patt D, Gordan L, Diaz M, et al. The impact of COVID-19 on cancer care: how the pandemic is delaying cancer diagnosis and treatment for American seniors. JCO Clin Cancer Inform. Oct 2020 [internet publication].Texto completo
272. Centers for Disease Control and Prevention. Sharp declines in breast and cervical cancer screening. Jun 2021 [internet publication].Texto completo
273. Lai AG, Pasea L, Banerjee A, et al. Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study. BMJ Open. 2020 Nov 17;10(11):e043828.Texto completo Resumo
274. Morris EJA, Goldacre R, Spata E, et al. Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study. Lancet Gastroenterol Hepatol. 2021 Mar;6(3):199-208.Texto completo Resumo
275. COVIDSurg Collaborative. Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study. Lancet Oncol. 2021 Nov;22(11):1507-17.Texto completo Resumo
276. Bofill Rodriguez M, Lethaby A, Farquhar C, et al. Interventions commonly available during pandemics for heavy menstrual bleeding: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2020 Jul 23;7:CD013651.Texto completo Resumo
277. Medicines and Healthcare products Regulation Agency. Coronavirus vaccine - weekly summary of Yellow Card reporting. Apr 2022 [internet publication].Texto completo
278. Royal College of Obstetricians and Gynaecologists. RCOG/FSRH respond to reports of 30,000 women’s periods affected after COVID-19 vaccine. Sep 2021 [internet publication].Texto completo
279. Medicines and Healthcare products Regulatory Agency. COVID-19 vaccines: updates for August 2021. Aug 2021 [internet publication].Texto completo
280. Campanile FC, Podda M, Arezzo A, et al. Acute cholecystitis during COVID-19 pandemic: a multisocietary position statement. World J Emerg Surg. 2020 Jun 8;15(1):38.Texto completo Resumo
281. Lin L, Wang X, Ren J, et al. Risk factors and prognosis for COVID-19-induced acute kidney injury: a meta-analysis. BMJ Open. 2020 Nov 10;10(11):e042573.Texto completo Resumo
282. Nugent J, Aklilu A, Yamamoto Y, et al. Assessment of acute kidney injury and longitudinal kidney function after hospital discharge among patients with and without COVID-19. JAMA Netw Open. 2021 Mar 1;4(3):e211095.Texto completo Resumo
283. Nephrology Journal Club. Acute kidney injury. Mar 2020 [internet publication].Texto completo
284. National Institute for Health and Care Excellence. COVID-19 rapid guideline: dialysis service delivery. Sep 2020 [internet publication].Texto completo
285. Zeidan AM, Boddu PC, Patnaik MM, et al. Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts. Lancet Haematol. 2020 Aug;7(8):e601-e612.Texto completo Resumo
286. American Society of Hematology. COVID-19 and adult ALL: frequently asked questions. Jan 2021 [internet publication].Texto completo
287. Maneikis K, Šablauskas K, Ringelevičiūtė U, et al. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study. Lancet Haematol. 2021 Aug;8(8):e583-92.Texto completo Resumo
288. Sun C, Pleyer C, Wiestner A. COVID-19 vaccines for patients with haematological conditions. Lancet Haematol. 2021 May;8(5):e312-4.Texto completo Resumo
289. Passamonti F, Cattaneo C, Arcaini L, et al. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study. Lancet Haematol. 2020 Oct;7(10):e737-45.Texto completo Resumo
290. National Cancer Research Institute Acute Myelogenous Leukaemia working party. Recommendations for the management of patients with AML during the COVID-19 outbreak. Oct 2020 [internet publication].Texto completo
291. Arlt W, Baldeweg SE, Pearce SHS, et al. Endocrinology in the time of COVID-19: management of adrenal insufficiency. Eur J Endocrinol. 2020 Jul;183(1):G25-32.Texto completo Resumo
292. British Society for Allergy and Immunology. Modifications for adult allergy services during the COVID-19 pandemic. Apr 2020 [internet publication].Texto completo
293. Cardinale F, Ciprandi G, Barberi S, et al. Consensus statement of the Italian society of pediatric allergy and immunology for the pragmatic management of children and adolescents with allergic or immunological diseases during the COVID-19 pandemic. Ital J Pediatr. 2020 Jun 16;46(1):84.Texto completo Resumo
294. Shah BN, Schlosshan D, McConkey HZR, et al. Outpatient management of heart valve disease following the COVID-19 pandemic: implications for present and future care. Heart. 2020 Oct;106(20):1549-54.Texto completo Resumo
295. American Society of Hematology. COVID-19 and aplastic anemia: frequently asked questions. May 2021 [internet publication].Texto completo
296. European Society for Blood and Marrow Transplantation. COVID-19 - bone marrow failure and PNH recommendations on behalf of the Severe Aplastic Anemia Working Party, European Group for Blood and Marrow Transplantation (EBMT). Mar 2020 [internet publication].Texto completo
297. NHS England. Eltrombopag as bridging therapy to haematopoietic stem cell transplant in severe or very severe aplastic anaemia during the COVID19 pandemic (in adults) (RPS 2006). Dec 2021 [internet publication].Texto completo
298. Global Initiative for Asthma. Global strategy for asthma management and prevention, 2022. [internet publication].Texto completo
299. Dolby T, Nafilyan V, Morgan A, et al. Relationship between asthma and severe COVID-19: a national cohort study. Thorax. 30 Mar 2022 [Epub ahead of print].Texto completo Resumo
300. Shi T, Pan J, Vasileiou E, et al. Risk of serious COVID-19 outcomes among adults with asthma in Scotland: a national incident cohort study. Lancet Respir Med. 2022 Apr;10(4):347-54.Texto completo Resumo
301. Bloom C, Drake T, Docherty A, et al. Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK. Lancet Respir Med. 2021 Jul;9(7):699-711.Texto completo Resumo
302. Aveyard P, Gao M, Lindson N, et al. Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study. Lancet Respir Med. 2021 Aug;9(8):909-23.Texto completo Resumo
303. National Institute for Health and Care Excellence. COVID-19 rapid guideline: severe asthma. Apr 2020 [internet publication].Texto completo
304. Licskai C, Yang CL, Ducharme FM, et al. Addressing therapeutic questions to help Canadian physicians optimize asthma management for their patients during the COVID-19 pandemic. Can J Resp Crit Care Sleep Med. 2020 Apr 30;4(2):73-6.Texto completo
305. American Lung Association. Asthma and COPD mythbusting with Dr. Juanita Mora. Mar 2020 [internet publication].Texto completo
306. European Lung Foundation. COVID-19 and lung disease Q&A. Mar 2021 [internet publication].Texto completo
307. Centers for Disease Control and Prevention. Clinical questions about COVID-19: questions and answers. Apr 2022 [internet publication].Texto completo
308. Houston SA, McDonald CM, Tyan CC, et al. Bronchoscopy during the COVID-19 pandemic: a Canadian Thoracic Society position statement. Jun 2021 [internet publication].Texto completo
309. British Thoracic Society. Advice for healthcare professionals treating people with asthma (adults) in relation to COVID-19. Nov 2020 [internet publication].Texto completo
310. Broadhurst R, Peterson R, Wisnivesky JP, et al. Asthma in COVID-19 hospitalizations: an overestimated risk factor? Ann Am Thorac Soc. 2020 Dec;17(12):1645-8.Texto completo Resumo
311. Davies GA, Alsallakh MA, Sivakumaran S, et al. Impact of COVID-19 lockdown on emergency asthma admissions and deaths: national interrupted time series analyses for Scotland and Wales. Thorax. 2021 Sep;76(9):867-73.Texto completo Resumo
312. Shah SA, Quint JK, Nwaru BI, et al. Impact of COVID-19 national lockdown on asthma exacerbations: interrupted time-series analysis of English primary care data. Thorax. 2021 Sep;76(9):860-66.Texto completo Resumo
313. Cortese S, Asherson P, Sonuga-Barke E, et al. ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group. Lancet Child Adolesc Health. 2020 Jun;4(6):412-14.Texto completo Resumo
314. British Society of Gastroenterology. A joint statement on vaccination for Sars-CoV-2 in patients with liver disease. Mar 2021 [internet publication].Texto completo
315. American Society of Breast Surgeons. Recommendations for prioritization, treatment and triage of patients with breast cancer during the COVID-19 pandemic. Apr 2020 [internet publication].Texto completo
316. Association of Breast Surgery. Recommendations on delivery of breast services during the COVID-19 pandemic. May 2020 [internet publication].Texto completo
317. Association of Breast Surgery and UK Breast Cancer Group. Joint statement on neoadjuvant chemotherapy during the COVID-19 pandemic. May 2020 [internet publication].Texto completo
318. Edmonds CE, Zuckerman SP, Conant EF. Management of unilateral axillary lymphadenopathy detected on breast MRI in the era of coronavirus disease (COVID-19) vaccination. AJR Am J Roentgenol. 2021 Oct;217(4):831-4.Texto completo Resumo
319. Robinson KA, Maimone S, Gococo-Benore DA, et al. Incidence of axillary adenopathy in breast imaging after COVID-19 vaccination. JAMA Oncol. 2021 Sep 1;7(9):1395-7.Texto completo Resumo
320. Royal College of Paediatrics and Child Health. National guidance for the management of children with bronchiolitis and lower respiratory tract infections during COVID-19. Dec 2021 [internet publication].Texto completo
321. UK and Ireland Neuroendocrine Tumour Society. COVID-19 pandemic strategy for the interim management of patients with neuroendocrine tumours/neuroendocrine cancer. Apr 2020 [internet publication].Texto completo Resumo
322. International Liaison Committee on Resuscitation. COVID-19: practical guidance for implementation. 2020 [internet publication].Texto completo
323. Resuscitation Council UK. Resuscitation Council UK statement on COVID-19 in relation to CPR and resuscitation in acute hospital settings. Aug 2021 [internet publication].Texto completo
324. Hsu A, Sasson C, Kudenchuk PJ, et al. 2021 Interim guidance to health care providers for basic and advanced cardiac life support in adults, children, and neonates with suspected or confirmed COVID-19. Circ Cardiovasc Qual Outcomes. 2021 Oct;14(10):e008396.Texto completo Resumo
325. Resuscitation of the drowned person in the era of COVID-19 disease: a common ground for recommendations, identification of research needs and a global call to action. Position Statement of the International Drowning Researchers' Alliance, International Life Saving Federation Medical Committee and International Maritime Rescue Federation. May 2020 [internet publication].Texto completo
326. Position Statement: cardiopulmonary resuscitation of patients with confirmed or suspected COVID-19 - 2020. Brazilian Association of Emergency Medicine (ABRAMEDE), Brazilian Society of Cardiology (SBC), Brazilian Association of Intensive Care Medicine (AMIB), and Brazilian Society of Anesthesiology (SBA). Jul 2020 [internet publication].Texto completo
327. Manto M, Dupre N, Hadjivassiliou M, et al. Management of patients with cerebellar ataxia during the COVID-19 pandemic: current concerns and future implications. Cerebellum. 2020 Aug;19(4):562-8.Texto completo Resumo
328. Royal College of Obstetricians and Gynaecologists. Guidance for maternal medicine services in the coronavirus (COVID-19) pandemic. Dec 2020 [internet publication].Texto completo
329. Royal College of Obstetricians and Gynaecologists. Coronavirus (COVID-19), pregnancy and women’s health. 2021 [internet publication].Texto completo
330. Ovadia C, Seed PT, Sklavounos A, et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers. Lancet. 2019 Mar 2;393(10174):899-909.Texto completo Resumo
331. Yonas E, Alwi I, Pranata R, et al. Effect of heart failure on the outcome of COVID-19 - A meta analysis and systematic review. Am J Emerg Med. 2021 Aug;46:204-11.Texto completo Resumo
332. Bhatt AS, Jering KS, Vaduganathan M, et al. Clinical outcomes in patients with heart failure hospitalized with COVID-19. JACC Heart Fail. 2021 Jan;9(1):65-73.Texto completo Resumo
333. CAPACITY-COVID Collaborative Consortium and LEOSS Study Group. Clinical presentation, disease course, and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across 18 countries. Eur Heart J. 2022 Mar 14;43(11):1104-20.Texto completo Resumo
334. Rey JR, Caro-Codón J, Rosillo SO, et al. Heart failure in COVID-19 patients: prevalence, incidence and prognostic implications. 2020 Dec;22(12):2205-15.Texto completo Resumo
335. Centers for Disease Control and Prevention. COVID-19: people at increased risk and other people who need to take extra precautions. Mar 2022 [internet publication].Texto completo
336. Fang X, Li S, Yu H, et al. Epidemiological, comorbidity factors with severity and prognosis of COVID-19: a systematic review and meta-analysis. Aging (Albany NY). 2020 Jul 13;12(13):12493-12503.Texto completo Resumo
337. Svensson P, Hofmann R, Häbel H, et al. Association between cardiometabolic disease and severe COVID-19: a nationwide case-control study of patients requiring invasive mechanical ventilation. BMJ Open. 2021 Feb 17;11(2):e044486.Texto completo Resumo
338. Biswas M, Rahaman S, Biswas TK, et al. Association of sex, age, and comorbidities with mortality in COVID-19 patients: a systematic review and meta-analysis. Intervirology. 9 Dec 2020 [Epub ahead of print].Texto completo Resumo
339. National Institute for Health and Care Excellence. COVID-19 rapid guideline: chronic kidney disease. May 2020 [internet publication].Texto completo
340. Carr EJ, Wu M, Harvey R, et al. Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients. Lancet. 2021 Sep 18;398(10305):1038-41.Texto completo Resumo
341. Sibbel S, McKeon K, Luo J, et al. Real-world effectiveness and immunogenicity of BNT162b2 and mRNA-1273 SARS-CoV2 vaccines in patients on hemodialysis. J Am Soc Nephrol. 2022 Jan;33(1):49-57.Texto completo Resumo
342. Hsu CM, Weiner DE, Manley HJ, et al. Seroresponse to SARS-CoV-2 vaccines among maintenance dialysis patients over 6 months. Clin J Am Soc Nephrol. 2022 Mar;17(3):403-13.Texto completo Resumo
343. Shen Q, Wang M, Che R, et al. Consensus recommendations for the care of children receiving chronic dialysis in association with the COVID-19 epidemic. Pediatr Nephrol. 2020 Jul;35(7):1351-57.Texto completo Resumo
344. Scarfò L, Chatzikonstantinou T, Rigolin GM, et al. COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus. Leukemia. 2020 Sep;34(9):2354-63.Texto completo Resumo
345. American Society of Hematology. COVID-19 and CLL: frequently asked questions. Feb 2021 [internet publication].Texto completo
346. Di Ciaccio P, McCaughan G, Trotman J, et al. Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic. Intern Med J. 2020 Jun;50(6):667-79.Texto completo Resumo
347. Herishanu Y, Avivi I, Aharon A, et al. Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia. Blood. 2021 Jun 10;137(23):3165-73.Texto completo Resumo
348. American Society of Hematology. COVID-19 and CML: frequently asked questions. Sep 2021 [internet publication].Texto completo
349. Noor FM, Islam M. Prevalence and associated risk factors of mortality among COVID-19 patients: a meta-analysis. J Community Health. 2020 Dec;45(6):1270-82.Texto completo Resumo
350. Rabbani G, Shariful Islam SM, Rahman MA, et al. Pre-existing COPD is associated with an increased risk of mortality and severity in COVID-19: a rapid systematic review and meta-analysis. Expert Rev Respir Med. 2021 Jan 7;1-12.Texto completo Resumo
351. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2022 report. Dec 2021 [internet publication].Texto completo
352. National Institute for Health and Care Excellence. COVID-19 rapid guideline: community-based care of patients with chronic obstructive pulmonary disease (COPD). Apr 2020 [internet publication].Texto completo
353. British Thoracic Society. COPD and COVID-19 for healthcare professionals. Apr 2020 [internet publication].Texto completo
354. British Thoracic Society. Pulmonary rehabilitation resource pack. Jun 2021 [internet publication].Texto completo
355. Tan JY, Conceicao EP, Wee LE, et al. COVID-19 public health measures: a reduction in hospital admissions for COPD exacerbations. Thorax. 2021 May;76(5):512-3.Texto completo Resumo
356. Shanthanna H, Strand NH, Provenzano DA, et al. Caring for patients with pain during the COVID-19 pandemic: consensus recommendations from an international expert panel. Anaesthesia. 2020 Jul;75(7):935-44.Texto completo Resumo
357. Drake TM, Fairfield CJ, Pius R, et al. Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study. Lancet Rheumatol. 2021 Jul;3(7):e498-506.Texto completo
358. Tuan WJ, Spotts H, Zgierska AE, et al. COVID-19 outcomes among adult patients treated with long-term opioid therapy for chronic non-cancer pain in the USA: a retrospective cohort study. BMJ Open. 2021 Nov 26;11(11):e056436.Texto completo Resumo
359. Bosworth ML, Ayoubkhani D, Nafilyan V, et al. Deaths involving COVID-19 by self-reported disability status during the first two waves of the COVID-19 pandemic in England: a retrospective, population-based cohort study. Lancet Public Health. 2021 Nov;6(11):e817-25.Texto completo Resumo
360. Klimek L, Jutel M, Bousquet J, et al. Management of patients with chronic rhinosinusitis during the COVID-19 pandemic - An EAACI Position Paper. Allergy. 2021 Mar;76(3):677-88.Texto completo Resumo
361. Große K, Kramer M, Trautwein C, et al. SARS-CoV-2 as an extrahepatic precipitator of acute-on-chronic liver failure. Liver Int. 2020 Jul;40(7):1792-3.Texto completo Resumo
362. Chandok N, Watt KD. Pain management in the cirrhotic patient: the clinical challenge. Mayo Clin Proc. 2010 May;85(5):451-8.Texto completo Resumo
363. Marjot T, Webb GJ, Barritt AS, et al. SARS-CoV-2 vaccination in patients with liver disease: responding to the next big question. Lancet Gastroenterol Hepatol. 2021 Mar;6(3):156-8.Texto completo Resumo
364. John BV, Deng Y, Scheinberg A, et al. Association of BNT162b2 mRNA and mRNA-1273 vaccines with COVID-19 infection and hospitalization among patients with cirrhosis. JAMA Intern Med. 2021 Oct 1;181(10):1306-14.Texto completo Resumo
365. US Food and Drug Administration. Safety alert regarding use of fecal microbiota for transplantation and additional safety protections pertaining to SARS-CoV-2 and COVID-19. Mar 2020 [internet publication].Texto completo
366. Trovato CM, Montuori M, Cucchiara S, et al. ESPGHAN 'biopsy-sparing' guidelines for celiac disease in children with low antitransglutaminase during COVID-19. Eur J Gastroenterol Hepatol. 2020 Dec;32(12):1523-6. Resumo
367. Centre for Evidence-Based Medicine. Are there any evidence-based ways of assessing dyspnoea (breathlessness) by telephone or video. Apr 2020 [internet publication].Texto completo
368. Centers for Disease Control and Prevention. Fungal diseases and COVID-19. Mar 2022 [internet publication].Texto completo
369. Alsaied T, Aboulhosn JA, Cotts TB, et al. Coronavirus disease 2019 (COVID-19) pandemic implications in pediatric and adult congenital heart disease. J Am Heart Assoc. 2020 Jun 16;9(12):e017224.Texto completo Resumo
370. Diller GP, Gatzoulis MA, Broberg CS, et al. Coronavirus disease 2019 in adults with congenital heart disease: a position paper from the ESC working group of adult congenital heart disease, and the International Society for Adult Congenital Heart Disease. Eur Heart J. 2021 May 14;42(19):1858-65.Texto completo Resumo
371. Radke RM, Frenzel T, Baumgartner H, et al. Adult congenital heart disease and the COVID-19 pandemic. Heart. 2020;106:1302-09.Texto completo
372. Faculty of Sexual and Reproductive Healthcare. FSRH CEU advice to support the provision of effective contraception during the COVID-19 outbreak. Mar 2020 [internet publication].Texto completo
373. Royal College of Obstetricians and Gynecologists, Faculty of Sexual and Reproductive Healthcare, and British Society of Abortion Care Providers Joint Guidance. Coronavirus (COVID-19) infection and abortion care. Jul 2020 [internet publication].Texto completo
374. Department of Health and Social Care. England to return to pre-pandemic system for early abortions. 24 February 2022 [internet publication].Texto completo
375. Ricciuto A, Lamb C, Benchimol E, et al. Inflammatory bowel disease clinical activity is associated with COVID-19 severity especially in younger patients. J Crohns Colitis. 2022 May 10;16(4):591-600.Texto completo Resumo
376. British Society of Gastroenterology. Expanded consensus advice for the management of IBD during the COVID-19 pandemic. Mar 2021 [internet publication].Texto completo
377. Quraishi MN, Cooney R, Brookes MJ, et al. An urgent need to institute COVID-19 testing in patients with IBD experiencing flares. Front Gastroenterol. 2020 Mar 27;11(4):330-1.Texto completo Resumo
378. Zingone F, Savarino EV. Viral screening before initiation of biologics in patients with inflammatory bowel disease during the COVID-19 outbreak. Lancet Gastroenterol Hepatol. 2020 Jun;5(6):525.Texto completo Resumo
379. International Organization for the Study of Inflammatory Bowel Disease. Care of the IBD patient requiring hospitalization or surgery during the COVID-19 pandemic. May 2020 [internet publication].Texto completo
380. International Organisation for the study of inflammatory bowel disease. IOIBD recommendations: best practice guidance for when to restart IBD therapy in patients who have suspected or confirmed COVID-19. May 2020 [internet publication].Texto completo
381. Kennedy N, Goodhand JR, Bewshea C, et al. Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab. Gut. 2021 May;70(5):865-75.Texto completo Resumo
382. American Gastroenterological Association. Gastroenterology professional society guidance on endoscopic procedures during the COVID-19 pandemic. Mar 2020 [internet publication].Texto completo
383. Iacucci M, Cannatelli R, Labarile N, et al. Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period. Lancet Gastroenterol Hepatol. 2020 Jun;5(6):598-606.Texto completo Resumo
384. Remzi FH, Panis Y, Spinelli A, et al. International Organization for the Study of Inflammatory Bowel Disease recommendations for surgery in patients with inflammatory bowel disease during the COVID-19 pandemic. Dis Colon Rectum. 2020 Jul;63(7):870-3.Texto completo Resumo
385. British Society of Gastroenterology. BSG inflammatory bowel disease section and clinical research group position statement on SARS-CoV2 vaccination. Sep 2021 [internet publication].Texto completo
386. Alexander JL, Kennedy NA, Ibraheim H, et al. COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study. Lancet Gastroenterol Hepatol. 2022 Apr;7(4):342-52.Texto completo Resumo
387. Syversen SW, Jyssum I, Tveter AT, et al. Immunogenicity and safety of standard and third dose SARS-CoV-2 vaccination in patients on immunosuppressive therapy. Arthritis Rheumatol. 4 May 2022 [Epub ahead of print].Texto completo Resumo
388. Sperger J, Shah K, Lu M, et al. Development and validation of multivariable prediction models for adverse COVID-19 outcomes in IBD patients. BMJ Open. 2021 Nov 12;11(11):e049740.Texto completo Resumo
389. Newell-Price J, Nieman L, Reincke M, et al. Endocrinology in the time of COVID-19: Management of Cushing's syndrome. Eur J Endocrinol. 2020 Jul;183(1):G1-7.Texto completo Resumo
390. Pivonello R, Ferrigno R, Isidori A, et al. COVID-19 and Cushing's syndrome: recommendations for a special population with endogenous glucocorticoid excess. Lancet Diabetes Endocrinol. 2020 Aug;8(8):654-6.Texto completo Resumo
391. Papadavid E, Scarisbrick J, Ortiz Romero P, et al. Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines. J Eur Acad Dermatol Venereol. 2020 Aug;34(8):1633-6.Texto completo Resumo
392. National Institute for Health and Care Excellence. COVID-19 rapid guideline: cystic fibrosis. Oct 2020 [internet publication].Texto completo
393. Wang Q, Davis PB, Gurney ME, et al. COVID-19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the US. Alzheimers Dement. 2021 Aug;17(8):1297-306.Texto completo Resumo
394. European Academy of Neurology. Dementia Scientific Panel report - COVID-19. Apr 2020 [internet publication].Texto completo
395. Livingston G, Rostamipour H, Gallagher P, et al. Prevalence, management, and outcomes of SARS-CoV-2 infections in older people and those with dementia in mental health wards in London, UK: a retrospective observational study. Lancet Psychiatry. 2020 Dec;7(12):1054-63.Texto completo Resumo
396. McGurnaghan SJ, Weir A, Bishop J, et al. Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland. Lancet Diabetes Endocrinol. 2021 Feb;9(2):82-93.Texto completo Resumo
397. Gregory JM, Slaughter JC, Duffus SH, et al. COVID-19 severity is tripled in the diabetes community: a prospective analysis of the pandemic's impact in type 1 and type 2 diabetes. Diabetes Care. 2021 Feb;44(2):526-32.Texto completo Resumo
398. Longmore DK, Miller JE, Bekkering S, et al. Diabetes and overweight/obesity are independent, nonadditive risk factors for in-hospital severity of COVID-19: an international, multicenter retrospective meta-analysis. Diabetes Care. 2021 Jun;44(6):1281-90.Texto completo Resumo
399. Barrett CE, Park J, Kompaniyets L, et al. Intensive care unit admission, mechanical ventilation, and mortality among patients with type 1 diabetes hospitalized for COVID-19 in the U.S. Diabetes Care. 2021 Aug;44(8):1788-96.Texto completo Resumo
400. Hartmann-Boyce J, Rees K, Perring JC, et al. Risks of and from SARS-CoV-2 infection and COVID-19 in people with diabetes: a systematic review of reviews. Diabetes Care. 2021 Dec;44(12):2790-811.Texto completo Resumo
401. Holman N, Knighton P, Kar P, et al. Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. Lancet Diabetes Endocrinol. 2020 Oct;8(10):823–33.Texto completo Resumo
402. Schlesinger S, Neuenschwander M, Lang A, et al. Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis. Diabetologia. 2021 Jul;64(7):1480-91.Texto completo Resumo
403. Wong R, Hall M, Vaddavalli R, et al. Glycemic control and clinical outcomes in U.S. patients with COVID-19: data from the National COVID Cohort Collaborative (N3C) database. Diabetes Care. 24 Feb 2022 [Epub ahead of print].Texto completo Resumo
404. Mahamat-Saleh Y, Fiolet T, Rebeaud M, et al. Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies. BMJ Open. 2021 Oct 25;11(10):e052777.Texto completo Resumo
405. Bae S, Kim SR, Kim MN, et al. Impact of cardiovascular disease and risk factors on fatal outcomes in patients with COVID-19 according to age: a systematic review and meta-analysis. Heart. 2021 Mar;107(5):373-80.Texto completo Resumo
406. Association of British Clinical Diabetologists. Concise advice on inpatient diabetes during COVID19 - front door guidance. Nov 2020 [internet publication].Texto completo
407. Coppelli A, Giannarelli R, Aragona M, et al. Hyperglycemia at hospital admission is associated with severity of the prognosis in patients hospitalized for COVID-19: the Pisa COVID-19 study. Diabetes Care. 2020 Oct;43(10):2345-8.Texto completo Resumo
408. Klonoff DC, Messler JC, Umpierrez GE, et al. Association between achieving inpatient glycemic control and clinical outcomes in hospitalized patients with COVID-19: a multicenter, retrospective hospital-based analysis. Diabetes Care. 2021 Feb;44(2):578-85.Texto completo Resumo
409. American Diabetes Association. COVID-19: if you do get sick, know what to do. Mar 2020 [internet publication].Texto completo
410. Diabetes and Primary Care. At a glance fact sheet: COVID-19 and diabetes. Apr 2020 [internet publication].Texto completo
411. Sathish T, Kapoor N, Cao Y, et al. Proportion of newly diagnosed diabetes in COVID-19 patients: a systematic review and meta-analysis. Diabetes Obes Metab. 2021 Mar;23(3):870-4.Texto completo Resumo
412. Barrett C, Koyama A, Alvarez P, et al. Risk for newly diagnosed diabetes >30 days after SARS-CoV-2 infection among persons aged <18 Years - United States, March 1, 2020-June 28, 2021. MMWR Morb Mortal Wkly Rep. 2022 Jan 14;71(2):59-65.Texto completo Resumo
413. Bornstein SR, Rubino F, Khunti K, et al. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol. 2020 Jun;8(6):546-50.Texto completo Resumo
414. National Inpatient Diabetes Covid-19 Response Group. COncise adVice on Inpatient Diabetes (COVID:Diabetes): dexamethasone/glucocorticosteroid therapy in Covid-19 patients: implications and guidance for the management of blood glucose in people with and without diabetes. Nov 2020 [internet publication].Texto completo
415. Dennis JM, Mateen BA, Sonabend R, et al. Type 2 diabetes and COVID-19-related mortality in the critical care setting: a national cohort study in England, March-July 2020. Diabetes Care. 2020 Oct 23:dc201444.Texto completo Resumo
416. Chen Y, Yang D, Cheng B, et al. Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication. Diabetes Care. 2020 Jul;43(7):1399-407.Texto completo Resumo
417. Mirani M, Favacchio G, Carrone F, et al. Impact of comorbidities and glycemia at admission and dipeptidyl peptidase 4 inhibitors in patients with type 2 diabetes with COVID-19: a case series from an academic hospital in Lombardy, Italy. Diabetes Care. Oct 2020 [internet publication].Texto completo Resumo
418. Wander PL, Lowy E, Beste LA, et al. Prior glucose-lowering medication use and 30-Day outcomes among 64,892 veterans with diabetes and COVID-19. Diabetes care. 2021 Dec;44(12):2708-13.Texto completo Resumo
419. Agarwal S, Schechter C, Southern W, et al. Preadmission diabetes-specific risk factors for mortality in hospitalized patients with diabetes and coronavirus disease 2019. Diabetes Care. 2020 Oct;43(10):2339-44.Texto completo Resumo
420. Yang W, Sun X, Zhang J, et al. The effect of metformin on mortality and severity in COVID-19 patients with diabetes mellitus. Diabetes Res Clin Pract. 22 Jun 2021 [Epub ahead of print].Texto completo Resumo
421. Ganesh A, Randall MD. Does metformin affect outcomes in COVID-19 patients with new or pre-existing diabetes mellitus? A systematic review and meta-analysis. Br J Clin Pharmacol. 4 Feb 2022 [Epub ahead of print].Texto completo Resumo
422. Patoulias D, Doumas M. Dipeptidyl peptidase-4 inhibitors and COVID-19-related deaths among patients with type 2 diabetes mellitus: a meta-analysis of observational studies. Endocrinol Metab (Seoul). 2021 Aug;36(4):904-8. Resumo
423. Kahkoska AR, Abrahamsen TJ, Alexander GC, et al. Association between glucagon-like peptide 1 receptor agonist and sodium-glucose cotransporter 2 inhibitor use and COVID-19 outcomes. Diabetes Care. 2021 Jul;44(7):1564-72.Texto completo Resumo
424. Hariyanto TI, Intan D, Hananto JE, et al. Pre-admission glucagon-like peptide-1 receptor agonist (GLP-1RA) and mortality from coronavirus disease 2019 (Covid-19): a systematic review, meta-analysis, and meta-regression. Diabetes Res Clin Pract. 2021 Sep;179:109031.Texto completo Resumo
425. Steenblock C, Schwarz PE, Ludwig B, et al. COVID-19 and metabolic disease: mechanisms and clinical management. Lancet Diabetes Endocrinol. 2021 Nov;9(11):786-98.Texto completo Resumo
426. British Association of Dermatologists. Covid-19 (Coronavirus): statement on dry skin and frequent handwashing to reduce Covid-19 risk. Mar 2020 [internet publication].Texto completo
427. Leonardi M, Hummelshoj L, Johnson N. Advice regarding COVID-19 and endometriosis for patients and healthcare providers. May 2020 [internet publication].Texto completo
428. European Academy of Neurology. Impact of COVID-19 on management of epilepsy. Apr 2020 [internet publication].Texto completo
429. European Reference Network for Rare or Low Prevalence Complex Diseases. COVID-19 and epilepsy - ERN EpiCARE recommendations. Apr 2020 [internet publication].Texto completo
430. Alsagaff MY, Mulia EPB, Maghfirah I, et al. Association of calcium channel blocker use with clinical outcome of COVID-19: A meta-analysis. Diabetes Metab Syndr. Sep-Oct 2021;15(5):102210.Texto completo Resumo
431. British Society for Allergy and Clinical Immunology. Modifications for paediatric allergy services during COVID-19 pandemic. Mar 2020 [internet publication].Texto completo
432. Klimek L, Jutel M, Akdis C, et al. Handling of allergen immunotherapy in the COVID-19 pandemic: an ARIA-EAACI statement. Allergy. 2020 Jul;75(7):1546-54.Texto completo Resumo
433. Mackie SL, Brouwer E, Conway R, et al. Clinical pathways for patients with giant cell arteritis during the COVID-19 pandemic: an international perspective. Lancet Rheumatol. 2021 Jan;3(1):e71-e82.Texto completo Resumo
434. NHS England. Tocilizumab for giant cell arteritis (GCA) during the COVID-19 pandemic (RPS 2007). Jul 2021 [internet publication].Texto completo
435. American College of Rheumatology. COVID-19 Vaccine Clinical Guidance for Patients with Rheumatic and Musculoskeletal Diseases (RMDs). Feb 2022.Texto completo Resumo
436. Landewé RBM, Kroon FPB, Alunno A, et al. EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update. Ann Rheum Dis. 23 Feb 2022 [Epub ahead of print].Texto completo Resumo
437. National Institute for Health and Care Excellence. COVID-19 rapid guideline: haematopoietic stem cell transplantation. Jul 2021 [internet publication].Texto completo
438. European Society for Blood and Marrow transplantation. COVID-19 and BMT. Jan 2022 [internet publication].Texto completo
439. American Society of Hematology. COVID-19 and multiple myeloma: frequently asked questions. Jan 2021 [internet publication].Texto completo
440. Sharma A, Bhatt NS, St Martin A, et al. Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study. Lancet Haematol. 2021 Mar;8(3):e185-93.Texto completo Resumo
441. Lupo-Stanghellini MT, Messina C, Marktel S, et al. Following-up allogeneic transplantation recipients during the COVID-19 pandemic. Lancet Haematol. 2020 May 22;S2352-3026(20)30176-9.Texto completo Resumo
442. Aydillo T, Gonzalez-Reiche AS, Aslam S, et al. Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer. N Engl J Med. 2020 Dec 24;383(26):2586-8.Texto completo Resumo
443. Ji D, Qin E, Xu J, et al. Non-alcoholic fatty liver diseases in patients with COVID-19: a retrospective study. J Hepatol. 2020 Aug;73(2):451-3.Texto completo Resumo
444. Barry A, Apisarnthanarax S, O'Kane GM, et al. Management of primary hepatic malignancies during the COVID-19 pandemic: recommendations for risk mitigation from a multidisciplinary perspective. Lancet Gastroenterol Hepatol. 2020 Aug;5(8):765-75.Texto completo Resumo
445. Narang A, Chan G, Aframian A, et al. Thirty-day mortality following surgical management of hip fractures during the COVID-19 pandemic: findings from a prospective multi-centre UK study. Int Orthop. 2020 Aug 29;1-9.Texto completo Resumo
446. Chlebeck JD, Birch CE, Blankstein M, et al. Nonoperative geriatric hip fracture treatment is associated with increased mortality: a matched cohort study. J Orthop Trauma. 2019 Jul;33(7):346-50. Resumo
447. Vizcarra P, Pérez-Elías MJ, Quereda C, et al. Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort. Lancet HIV. 2020 Aug;7(8):e554-64.Texto completo Resumo
448. Gervasoni C, Meraviglia P, Riva A, et al. Clinical features and outcomes of HIV patients with coronavirus disease 2019. Clin Infect Dis. 2020 Nov 19;71(16):2276-8.Texto completo Resumo
449. Byrd KM, Beckwith CG, Garland JM, et al. SARS-CoV-2 and HIV coinfection: clinical experience from Rhode Island, United States. J Int AIDS Soc. 2020 Jul 19;23(7):e25573.Texto completo Resumo
450. Del Amo J, Polo R, Moreno S, et al. Incidence and severity of COVID-19 in HIV-positive persons receiving antiretroviral therapy: a cohort study. Ann Intern Med. 2020 Oct 6;173(7):536-41.Texto completo Resumo
451. Nomah DK, Reyes-Urueña J, Díaz Y, et al. Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study. Lancet HIV. 2021 Nov;8(11):e701-10.Texto completo Resumo
452. Spinelli M, Lynch K, Yun C, et al. SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study. Lancet HIV. 2021 Jun;8(6):e334-41.Texto completo Resumo
453. Yang X, Sun J, Patel RC, et al. Associations between HIV infection and clinical spectrum of COVID-19: a population level analysis based on US National COVID Cohort Collaborative (N3C) data. Lancet HIV. 2021 Nov;8(11):e690-700.Texto completo Resumo
454. Mirzaei H, McFarland W, Karamouzian M, et al. COVID-19 among people living with HIV: a systematic review. AIDS Behav. 2021 Jan;25(1):85-92.Texto completo Resumo
455. Tesoriero JM, Swain CE, Pierce J, et al. COVID-19 outcomes among persons living with or without diagnosed HIV infection in New York State. JAMA Netw Open. 2021 Feb 1;4(2):e2037069.Texto completo Resumo
456. Boulle A, Davies MA, Hussey H, et al. Risk factors for COVID-19 death in a population cohort study from the Western Cape Province, South Africa. Clin Infect Dis. Aug 2020 [internet publication].Texto completo Resumo
457. Chanda D, Minchella PA, Kampamba D, et al. COVID-19 severity and COVID-19-associated deaths among hospitalized patients with HIV infection - Zambia, March-December 2020. MMWR Morb Mortal Wkly Rep. 2021 Jun 4;70(22):807-10.Texto completo Resumo
458. US Department of Health and Human Services. Interim guidance for COVID-19 and persons with HIV. Feb 2022 [internet publication].Texto completo
459. European AIDS Clinical Society (EACS) and British HIV Association (BHIVA). EACS & BHIVA statement on risk of COVID-19 for people living with HIV (PLWH). Apr 2020 [internet publication].Texto completo
460. Infectious Disease Society of America and HIV Medicine Association. COVID-19: special considerations for people living with HIV. Dec 2020 [internet publication].Texto completo
461. European AIDS Clinical Society. COVID-19 and HIV. BHIVA, DAIG, EACS, GESIDA & Polish Scientific AIDS Society. Statement on risk of COVID-19 for people living with HIV (PLWH). May 2020 [internet publication].Texto completo
462. Netto LC, Ibrahim KY, Picone CM, et al. Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study. Lancet HIV. 2022 May;9(5):e323-e331.Texto completo Resumo
463. Guidance for the management of patients with lymphoma during the COVID19 health emergency: a statement from a panel of UK lymphoma experts. Mar 2020 [internet publication].Texto completo
464. American Society of Hematology. COVID-19 and Hodgkin lymphoma: frequently asked questions. Apr 2022 [internet publication].Texto completo
465. National Institute for Health and Care Excellence. COVID-19 rapid guideline: interstitial lung disease. May 2020 [internet publication].Texto completo
466. Canadian Thoracic Society. Optimizing care for patients with interstitial lung disease during the COVID-19 pandemic. Aug 2020 [internet publication].Texto completo
467. American Society for Hematology. COVID-19 and ITP: frequently asked questions. Apr 2021 [internet publication].Texto completo
468. Stowe J, Tessier, E, Zhao H, et al. Interactions between SARS-CoV-2 and Influenza and the impact of coinfection on disease severity: A test negative design. Int J Epidemiol. 2021;50(4):1124-33.Texto completo
469. Swets MC, Russell CD, Harrison EM, et al. SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses. Lancet. Apr 16;399(10334):1463-4.Texto completo Resumo
470. Gleason J, Ross W, Alexander Fossi A, et al. The devastating impact of Covid-19 on individuals with intellectual disabilities in the United States. NEJM Catalyst. Mar 2021 [internet publication].Texto completo
471. Williamson E, McDonald HI, Bhaskaran K, et al. Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform. BMJ. 2021 Jul 14;374:n1592.Texto completo Resumo
472. Alexander R, Ravi A, Barclay H, et al. Guidance for the treatment and management of COVID-19 among people with intellectual disabilities. J Policy Pract Intellect Disabil. 2020 Jun 10 [Epub ahead of print].Texto completo Resumo
473. Sultan S, Altayar O, Siddique SM, et al. AGA Institute rapid review of the GI and liver manifestations of COVID-19, meta-analysis of international data, and recommendations for the consultative management of patients with COVID-19. Gastroenterology. 2020 Jul;159(1):320-34.e27.Texto completo Resumo
474. European Academy of Neurology. Headache in COVID-19 pandemic. Apr 2020 [internet publication].Texto completo
475. Moorthy A, Gaikwad R, Krishna S, et al. SARS-CoV-2, Uncontrolled diabetes and corticosteroids-an unholy trinity in invasive fungal infections of the maxillofacial region? A retrospective, multi-centric analysis. J Maxillofac Oral Surg. 2021 Mar 6;20(3):1-8.Texto completo Resumo
476. John TM, Jacob CN, Kontoyiannis DP, et al. When uncontrolled diabetes mellitus and severe COVID-19 converge: the perfect storm for mucormycosis. J Fungi (Basel). 2021 Apr 15;7(4):298.Texto completo Resumo
477. Joshi S, Telang R, Tambe M, et al. Outbreak of mucormycosis in coronavirus disease patients, Pune, India. Emerg Infect Dis. 2021 Sep 29;28(1).Texto completo Resumo
478. Mejía-Santos H, Montoya S, Chacón-Fuentes R, et al. Notes from the field: mucormycosis cases during the COVID-19 pandemic - Honduras, May-September 2021. MMWR Morb Mortal Wkly Rep. 2021 Dec 17;70(50):1747-9.Texto completo Resumo
479. Dulski TM, DeLong M, Garner K, et al. Notes from the field: COVID-19-associated mucormycosis - Arkansas, July-September 2021. MMWR Morb Mortal Wkly Rep. 2021 Dec 17;70(50):1750-1.Texto completo Resumo
480. Muthu V, Agarwal R, Patel A, et al. Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and Academy of Pulmonary Sciences, India. Lancet Infect Dis. 4 Apr 2022 [Epub ahead of print].Texto completo Resumo
481. Department of Health Research Ministry of Health and Family Welfare Government of India. Evidence based advisory in the time of Covid-19. Screening, diagnosis & management of mucormycosis. 2021 [internet publication].Texto completo
482. Terpos E, Engelhardt M, Cook G, et al. Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN). Leukemia. 2020 Aug;34(8):2000-11.Texto completo Resumo
483. British Society for Haematology. UK Myeloma Forum guidance to support medical decision-making in the management of myeloma patients during the COVID-19 (Coronavirus) outbreak. Mar 2020 [internet publication].Texto completo
484. Medicines and Healthcare products Regulatory Agency guidance. Immunomodulatory drugs: temporary pregnancy prevention guidance during coronavirus (COVID-19). May 2020 [internet publication].Texto completo
485. Terpos E, Trougakos IP, Gavriatopoulou M, et al. Low neutralizing antibody responses against SARS-CoV-2 in elderly myeloma patients after the first BNT162b2 vaccine dose. Blood. 2021 Jul 1;137(26):3674-6.Texto completo Resumo
486. Ludwig H, Sonneveld P, Facon T, et al. COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network. Lancet Haematol. 2021 Dec;8(12):e934-46.Texto completo Resumo
487. Association of British Neurologists. ABN guidance on the use of disease-modifying therapies in multiple sclerosis in response to the COVID-19 pandemic. Nov 2020 [internet publication].Texto completo
488. National Multiple Sclerosis Society. MS treatment guidelines during coronavirus. 2020 [internet publication].Texto completo
489. Louapre C, Collongues N, Stankoff B, et al. Clinical characteristics and outcomes in patients with coronavirus disease 2019 and multiple sclerosis. JAMA Neurol. 2020 Jun 26;77(9):1-10.Texto completo Resumo
490. Salter A, Fox RJ, Newsome SD, et al. Outcomes and risk factors associated with SARS-CoV-2 infection in a North American registry of patients with multiple sclerosis. JAMA Neurol. 2021 Jun 1;78(6):699-708.Texto completo Resumo
491. MS Society Medical Advisers consensus statement on MS treatments and COVID-19 vaccines. Jan 2022 [Internet publication].Texto completo
492. Achiron A, Mandel M, Dreyer-Alster S, et al. Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies. Ther Adv Neurol Disord. 2021 Apr 22;14:17562864211012835.Texto completo Resumo
493. Disanto G, Sacco R, Bernasconi E, et al. Association of disease-modifying treatment and anti-CD20 infusion timing with humoral response to 2 SARS-CoV-2 vaccines in patients with multiple sclerosis. JAMA Neurol. 2021 Dec 1;78(12):1529-31.Texto completo Resumo
494. Brill L, Rechtman A, Zveik O, et al. Humoral and T-cell response to SARS-CoV-2 vaccination in patients with multiple sclerosis treated with ocrelizumab. JAMA Neurol. 2021 Dec 1;78(12):1510-4.Texto completo Resumo
495. König M, Torgauten HM, Tran TT, et al. Immunogenicity and safety of a third SARS-CoV-2 vaccine dose in patients with multiple sclerosis and weak immune response after COVID-19 vaccination. JAMA Neurol. 2022 Mar 1;79(3):307-9.Texto completo Resumo
496. Madelon N, Heikkilä N, Sabater Royo I, et al. Omicron-specific cytotoxic T-cell responses after a third dose of mRNA COVID-19 vaccine among patients with multiple sclerosis treated with ocrelizumab. JAMA Neurol. 2022 Apr 1;79(4):399-404.Texto completo Resumo
497. American Society for Hematology. COVID-19 and aggressive lymphoma: frequently asked questions. Apr 2022 [internet publication].Texto completo
498. Katsoularis I, Fonseca-Rodríguez O, Farrington P, et al. Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study. Lancet. 2021 Aug 14;398(10300):599-607.Texto completo Resumo
499. Chieffo A, Stefanini GG, Price S, et al. EAPCI position statement on invasive management of acute coronary syndromes during the COVID-19 pandemic. Eur Heart J. 2020 May 14;41(19):1839-51.Texto completo Resumo
500. Rashid M, Timmis 3A, Kinnaird T, et al. Racial differences in management and outcomes of acute myocardial infarction during COVID-19 pandemic. Heart. 2021 May;107(9):734-40.Texto completo Resumo
501. Public Health England. Excess weight and COVID-19: insights from new evidence. Jul 2020 [internet publication].Texto completo
502. Hendren NS, de Lemos JA, Ayers C, et al. Association of body mass index and age with morbidity and mortality in patients hospitalized with COVID-19: results from the American Heart Association COVID-19 cardiovascular disease registry. Circulation. 2021 Jan 12;143(2):135-44.Texto completo Resumo
503. Popkin BM, Du S, Green WD, et al. Individuals with obesity and COVID-19: a global perspective on the epidemiology and biological relationships. Obes Rev. 2020 Nov;21(11):e13128.Texto completo Resumo
504. Kompaniyets L, Goodman A, Belay B, et al. Body mass index and risk for COVID-19-related hospitalization, intensive care unit admission, invasive mechanical ventilation, and death - United States, March-December 2020. MMWR Morb Mortal Wkly Rep. 2021 Mar 12;70(10):355-61.Texto completo Resumo
505. Arulanandam B, Beladi H, Chakrabarti A. COVID-19 mortality and the overweight: cross-country evidence. Public Health Pract (Oxf). 2021 Nov;2:100179.Texto completo Resumo
506. Gao M, Piernas C, Astbury NM, et al. Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study. Lancet Diabetes Endocrinol. 2021 Jun;9(6):350-9.Texto completo Resumo
507. Holt H, Talaei M, Greenig M, et al. Risk factors for developing COVID-19: a population-based longitudinal study (COVIDENCE UK). Thorax. 30 Nov 2021 [Epub ahead of print].Texto completo Resumo
508. Aminian A, Bena J, Pantalone KM, et al. Association of obesity with post-acute sequelae of COVID-19 (PASC). Diabetes Obes Metab. 2021 Sep;23(9):2183-8.Texto completo Resumo
509. Lange SJ, Kompaniyets L, Freedman DS, et al. Longitudinal trends in body mass index before and during the COVID-19 pandemic among persons aged 2-19 years - United States, 2018-2020. MMWR Morb Mortal Wkly Rep. 2021 Sep 17;70(37):1278-83.Texto completo Resumo
510. Wanga V, Gerdes M, Shi D, et al. Characteristics and clinical outcomes of children and adolescents aged <18 years hospitalized with COVID-19 - six hospitals, United States, July-August 2021. MMWR Morb Mortal Wkly Rep. 2021 Dec 31;70(5152):1766-72.Texto completo Resumo
511. Maas MB, Kim M, Malkani RG, et al. Obstructive sleep apnea and risk of COVID-19 infection, hospitalization and respiratory failure. Sleep Breath. 2020 Sep 29:1-3 [internet publication].Texto completo Resumo
512. Cariou B, Hadjadj S, Wargny M, et al. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia. 2020 Aug;63(8):1500-15.Texto completo Resumo
513. Miller MA, Cappuccio FP. A systematic review of COVID-19 and obstructive sleep apnoea. Sleep Med Rev. 2020 Sep 8;55:101382 [internet publication].Texto completo Resumo
514. European Rhinologic Society. Information for rhinologists on COVID-19. Apr 2020 [internet publication].Texto completo
515. Royal College of Ophthalmologists. Glaucoma service management plans during COVID-19. Mar 2020 [internet publication].Texto completo
516. Gittoes NJ, Criseno S, Appelman-Dijkstra NM, et al. Endocrinology in the time of COVID-19: management of calcium disorders and osteoporosis. Eur J Endocrinol. 2020 Aug;183(2):G57-65.Texto completo Resumo
517. Yu EW, Tsourdi E, Clarke BL, et al. Osteoporosis management in the era of COVID-19. J Bone Miner Res. 2020 Jun;35(6):1009-13.Texto completo Resumo
518. Mikuls TR, Johnson SR, Fraenkel L, et al. American College of Rheumatology guidance for the management of rheumatic disease in adult patients during the COVID‐19 pandemic: version 3. 2021 Feb;73(2):e1-12.Texto completo Resumo
519. Wahezi DM, Lo MS, Rubinstein TB, et al. American College of Rheumatology guidance for the management of pediatric rheumatic disease during the COVID-19 pandemic: version 2. Arthritis Rheumatol. 2021 Aug;73(8):e46-59.Texto completo Resumo
520. Center to Advance Palliative Care. COVID-19 response training. Apr 2020 [internet publication].Texto completo
521. Jones CM, Radhakrishna G, Aitken K, et al. Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position. Br J Cancer. 2020 Sep;123(5):709-13.Texto completo Resumo
522. Miocinovic S, Ostrem JL, Okun MS, et al. Recommendations for deep brain stimulation device management during a pandemic. J Parkinsons Dis. 2020 Jul 28;10(3):903-10.Texto completo Resumo
523. Zaorsky NG, Yu JB, McBride SM, et al. Prostate cancer radiotherapy recommendations in response to COVID-19. Adv Radiat Oncol. 2020 Apr 1;5(4):659-65.Texto completo Resumo
524. American Society for Hematology. COVID-19 and VTE-anticoagulation: frequently asked questions. Feb 2022 [internet publication].Texto completo
525. National Institute for Health and Care Excellence. COVID-19 rapid guideline: renal transplantation. Aug 2020 [internet publication].Texto completo
526. British Transplantation Society and Renal Association. Guidance on management of transplant recipients diagnosed with or suspected of having COVID-19. Jul 2020 [internet publication].Texto completo
527. The Transplantation Society. Guidance on coronavirus for transplant clinicians. Jun 2020 [internet publication].Texto completo
528. Kidney Advisory Group, NHS Blood and Transplant. Guidance for re-opening and expansion of kidney transplant programs and COVID-19. Jun 2020 [internet publication].Texto completo
529. Boyarsky BJ, Werbel WA, Avery RK, et al. Antibody response to 2-Dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients. JAMA. 2021 Jun 1;325(21):2204-6.Texto completo Resumo
530. Marion O, Del Bello A, Abravanel F, et al. Safety and immunogenicity of anti-SARS-CoV-2 messenger RNA vaccines in recipients of solid organ transplants. Ann Intern Med. 2021 Sep;174(9):1336-8.Texto completo Resumo
531. Kumar D, Ferreira VH, Hall VG, et al. Neutralization of SARS-CoV-2 variants in transplant recipients after two and three doses of mRNA-1273 vaccine : secondary analysis of a randomized trial. Ann Intern Med. 2022 Feb;175(2):226-33.Texto completo Resumo
532. Reindl-Schwaighofer R, Heinzel A, Mayrdorfer M, et al. Comparison of SARS-CoV-2 antibody response 4 weeks after homologous vs heterologous third vaccine dose in kidney transplant recipients: a randomized clinical trial. JAMA Intern Med. 2022 Feb 1;182(2):165-71.Texto completo Resumo
533. Lee AR, Wong SY, Chai LY, et al. Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis. BMJ. 2022 Mar 2;376:e068632.Texto completo Resumo
534. Zahradka I, Petr V, Modos I, et al. Association between SARS-CoV-2 Messenger RNA Vaccines and lower infection rates in kidney transplant recipients : a registry-based report. Ann Intern Med. 3 May 2022 [Epub ahead of print].Texto completo Resumo
535. D'Silva KM, Jorge A, Cohen A, et al. COVID-19 outcomes in patients with systemic autoimmune rheumatic diseases compared to the general population: a US multicenter, comparative cohort study. Arthritis Rheumatol. 2021 Jun;73(6):914-20.Texto completo Resumo
536. England BR, Roul P, Yang Y, et al. Risk of COVID-19 in rheumatoid arthritis: a national Veterans Affairs matched cohort study in at-risk individuals. Arthritis Rheumatol. 2021 Dec;73(12):2179-88.Texto completo Resumo
537. Panamerican League of Associations for Rheumatology. Recommendations for patients on coronavirus. Apr 2020 [internet publication].Texto completo
538. British Society for Rheumatology. COVID-19: guidance. Mar 2022 [internet publication].Texto completo
539. National Institute for Health and Care Excellence. COVID-19 rapid guideline: rheumatological autoimmune, inflammatory and metabolic bone disorders. Mar 2021 [internet publication].Texto completo
540. British Society for Rheumatology. Corticosteroid guidance. Nov 2020 [internet publication].Texto completo
541. Medicines and Healthcare Products Regulatory Agency. Central Alerting System. Ibuprofen and coronavirus (COVID-19). Apr 2020 [internet publication].Texto completo
542. National Institute for Health and Care Excellence. COVID-19 rapid evidence summary: long-term use of non-steroidal anti-inflammatory drugs (NSAIDs) for people with or at risk of COVID-19. May 2020 [internet publication].Texto completo
543. US Food and Drug Administration. FDA advises patients on use of non-steroidal anti-inflammatory drugs (NSAIDs) for COVID-19. Mar 2020 [internet publication].Texto completo
544. European Medicines Agency. EMA gives advice on the use of non-steroidal anti-inflammatories for COVID-19. Mar 2020 [internet publication].Texto completo
545. Haberman RH, Castillo R, Chan A, et al. COVID-19 in patients with inflammatory arthritis: a prospective study on the effects of comorbidities and disease-modifying antirheumatic drugs on clinical outcomes. Arthritis Rheumatol. 2020 Dec;72(12):1981-9.Texto completo Resumo
546. European League Against Rheumatism. EULAR guidance for patients COVID-19 outbreak. Apr 2020 [internet publication].Texto completo
547. Gianfrancesco MA, Leykina LA, Izadi Z, et al. Association of race and ethnicity with COVID-19 outcomes in rheumatic disease: data from the COVID-19 Global Rheumatology Alliance Physician Registry. Arthritis Rheumatol. 2021 Mar;73(3):374-80.Texto completo Resumo
548. Arthritis and Musculoskeletal alliance. Principles for COVID-19 vaccination in musculoskeletal and rheumatology for clinicians. Apr 2022 [internet publication].Texto completo
549. Sweiss NJ, Korsten P, Syed HJ, et al. When the game changes: guidance to adjust sarcoidosis management during the coronavirus disease 2019 pandemic. Chest. 2020 Sep;158(3):892-95.Texto completo Resumo
550. Panepinto JA, Brandow A, Mucalo L, et al. Coronavirus disease among persons with sickle cell disease, United States, March 20-May 21, 2020. Emerg Infect Dis. 2020 Oct;26(10):2473-6.Texto completo Resumo
551. Clift AK, Saatci D, Coupland CAC, et al. Sickle cell disorders and severe COVID-19 outcomes: a cohort study. Ann Intern Med. 2021 Oct;174(10):1483-7.Texto completo Resumo
552. Sickle Cell Disease Association of America. Sickle cell disease and COVID-19: provider advisory. May 2020 [internet publication].Texto completo
553. World Health Organization. Smoking and COVID-19: scientific brief. Jun 2020 [internet publication].Texto completo
554. Hopkinson NS, Rossi N, El-Sayed Moustafa J, et al. Current smoking and COVID-19 risk: results from a population symptom app in over 2.4 million people. Thorax. 2021 Jul;76(7):714-22. Resumo
555. Clift AC, von Ende A, Tan P, et al. Smoking and COVID-19 outcomes: an observational and Mendelian randomisation study using the UK Biobank cohort. Thorax. 2022 Jan;77(1):65-73.Texto completo Resumo
556. Saad M, Kennedy KF, Imran H, et al. Association between COVID-19 diagnosis and in-hospital mortality in patients hospitalized with ST-segment elevation myocardial infarction. JAMA. 2021 Nov 16;326(19):1940-52.Texto completo Resumo
557. AHA/ASA Stroke Council Leadership. Temporary emergency guidance to US stroke centers during the coronavirus disease 2019 (COVID-19) pandemic: on behalf of the American Heart Association/American Stroke Association Stroke Council Leadership. Stroke. 2020 Jun;51(6):1910-12.Texto completo Resumo
558. Stauffer WM, Alpern JD, Walker PF. COVID-19 and dexamethasone: a potential strategy to avoid steroid-related strongyloides hyperinfection. JAMA. 2020 Jul 30;324(7):623-4.Texto completo
559. Wainwright JJ, Mikre M, Whitley P, et al. Analysis of drug test results before and after the US declaration of a national emergency concerning the COVID-19 outbreak. JAMA. 2020 Sep 18;324(16):1674-7.Texto completo Resumo
560. Ochalek TA, Cumpston KL, Wills BK, et al. Nonfatal opioid overdoses at an urban emergency department during the COVID-19 pandemic. JAMA. 2020 Sep 18;324(16):1673-74.Texto completo Resumo
561. Mason M, Arukumar P, Feinglass J, et al. The pandemic stay-at-home order and opioid-involved overdose fatalities. JAMA. 2021 Jun 22;325(24):2495-6.Texto completo Resumo
562. Friedman J, Beletsky L, Schriger DL. Overdose-related cardiac arrests observed by emergency medical services during the US COVID-19 epidemic. JAMA Psychiatry. 2021 May 1;78(5):562-4.Texto completo Resumo
563. Centers for Disease Control and Prevention. Increase in fatal drug overdoses across the United States driven by synthetic opioids before and during the COVID-19 pandemic. Dec 2020 [internet publication].Texto completo
564. Pollard MS, Tucker JS, Green HD. Changes in adult alcohol use and consequences during the COVID-19 pandemic in the US. JAMA Netw Open. 2020;3(9):e2022942.Texto completo Resumo
565. White AM, Castle IJ, Powell PA, et al. Alcohol-related deaths during the COVID-19 pandemic. JAMA. 2022 May 3;327(17):1704-6.Texto completo Resumo
566. U.S. Food and Drug Administration. Possible false RPR reactivity with BioPlex 2200 Syphilis Total & RPR test kit following a COVID-19 vaccine - letter to clinical laboratory staff and health care providers. Dec 2021 [internet publication].Texto completo
567. Fernandez-Ruiz R, Masson M, Kim MY, et al. Leveraging the United States epicenter to provide insights on COVID-19 in patients with systemic lupus erythematosus. Arthritis Rheumatol. 2020 Dec;72(12):1971-80.Texto completo Resumo
568. Rutherford MA, Scott J, Karabayas M, et al. Risk factors for severe outcomes in patients with systemic vasculitis and COVID-19: a binational, registry-based cohort study. Arthritis Rheumatol. 2021 Sep;73(9):1713-9.Texto completo Resumo
569. American Society for Haematology. COVID-19 and thalassemia: frequently asked questions. Jan 2022 [internet publication].Texto completo
570. Farmakis D, Giakoumis A, Cannon L, et al. COVID-19 and thalassaemia: a position statement of the Thalassaemia International Federation. Eur J Haematol. 2020 Oct;105(4):378-86.Texto completo Resumo
571. American Society for Hematology. COVID-19 and thrombotic thrombocytopenic purpura: frequently asked questions. Apr 2022 [internet publication].Texto completo
572. Centers for Disease Control and Prevention. Interim clinical considerations for use of COVID-19 vaccines currently authorized in the United States. Mar 2022 [internet publication].Texto completo
573. NHS England. COVID-19: Provision of tuberculosis services update. Feb 2021 [internet publication].Texto completo
574. World Health Organization. Tuberculosis and COVID-19. 2020 [Internet publication].Texto completo
575. World Health Organization. COVID-19 highlights urgent need to reboot global effort to end tuberculosis. Mar 2021 [internet publication].Texto completo
576. Dheda D, Perumal T, Moultrie H, et al. The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions. Lancet Respir Med. 2022 Mar 23 [Epub ahead of print].Texto completo Resumo
577. Sebastian S, Walker GJ, Kennedy NA, et al. Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study. Lancet Gastroenterol Hepatol. 2021 Apr;6(4):271-81.Texto completo Resumo
578. International Uveitis Study Group. Evolving consensus experience of the IUSG-IOIS-FOIS with uveitis in the time of COVID-19 infection. Apr 2020 [internet publication].Texto completo
579. Hung JCH, Li KKW. Implications of COVID-19 for uveitis patients: perspectives from Hong Kong. Eye (Lond). 2020;34(7):1163-64.Texto completo Resumo
580. Mao R, Qiu Y, He JS, et al. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020 Jul;5(7):667-78.Texto completo Resumo
581. Pan L, Mu M, Yang P, et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am J Gastroenterol. 2020 May;115(5):766-73.Texto completo Resumo
582. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9.Texto completo Resumo
583. Zheng S, Fan J, Yu F, et al. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study. BMJ. 2020 Apr 21;369:m1443.Texto completo Resumo
584. British Society for Haematology. BSH advice on vitamin B12 replacement during the COVID-19 pandemic. May 2020 [internet publication].Texto completo
585. Hurst EA, Mellanby RJ, Handel I, et al. Vitamin D insufficiency in COVID-19 and influenza A, and critical illness survivors: a cross-sectional study. BMJ Open. 2021 Oct 22;11(10):e055435.Texto completo Resumo
586. Dror AA, Morozov N, Daoud A, et al. Pre-infection 25-hydroxyvitamin D3 levels and association with severity of COVID-19 illness. PLoS One. 2022 Feb 3;17(2):e0263069.Texto completo Resumo
587. National Institute for Health and Care Excellence. COVID-19 rapid guideline: vitamin D. Dec 2020 [internet publication].Texto completo
O uso deste conteúdo está sujeito ao nosso aviso legal